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ABSTRACT 
 
    The type VI intermediate filament (IF) protein synemin is a very large, unique member 
of the IF protein superfamily. Synemin associates with the major type III IF protein desmin 
and/or vimentin forming heteropolymeric intermediate filaments (IFs) within mammalian 
muscle cells. Previous studies in our lab showed that avian synemin interacts with vinculin 
and α-actinin, both of which are cytoskeletal proteins present in adhesion sites such as the 
focal adhesions within cells. Thus, synemin may link the heteropolymeric IFs to adhesion 
sites within mammalian muscle cells or within some non-muscle cells that express synemin. 
At least two isoforms of synemin, namely α- and β-synemin, are present in mammals. The 
larger α-synemin is identical with the smaller β-synemin, with the only exception being that 
the slightly smaller β-synemin lacks a 312 amino acid insert (SNTIII) near the end of the 
long C-terminal tail domain. Whether the two mammalian synemin isoforms have different 
functions is unclear. Studies in this dissertation provide evidence that the two large 
mammalian (human) synemin isoforms interact differentially with several cytoskeletal 
proteins and thereby may fulfill different cellular functions. Mapping the binding site(s) of 
human synemins within vinculin and talin by in vitro protein-protein interaction assays 
revealed that SNTIII, which is absent in β-synemin, interacts specifically with both vinculin 
and talin. Transient expression of enhanced green fluorescent protein (EGFP)-tagged SNTIII 
co-localized with vinculin and talin at focal adhesion sites within mammalian cells. Confocal 
microscope analysis of intracellular localizations of endogenous synemin and vinculin/talin 
indicated that synemin co-localized with vinculin and talin at the sites of costameres, which 
are considered specialized focal adhesions located periodically along and immediately 
subjacent to the sarcolemma of mammalian striated muscle cells. These results indicated that 
mammalian α-synemin, but not β-synemin, interacts directly with the cytoskeletal proteins 
vinculin and talin within mammalian cells. To elucidate the possible functions of, and to 
identify novel interacting proteins for, the smaller β-synemin within cells, yeast two-hybrid 
screening of a human adult skeletal muscle cDNA library was performed using the entire tail 
domain of human β-synemin (SNβΤ) as the bait. The LIM domain protein zyxin was 
identified as an interaction partner of β-synemin. The interaction was further confirmed by 
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several in vitro protein-protein interaction assays. Furthermore, over-expression of the 
zyxin-binding region of synemin within mammalian cells blocked the localizations of 
endogenous zyxin to the focal adhesions without disrupting normal cellular architectures. 
Knockdown synemin expression within cells by siRNA resulted in significantly 
compromised cell adhesion and migration. These results in toto indicate that mammalian 
(human) synemin isoforms participate in the focal adhesion dynamics and are essential for 
cell adhesion and cell motility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
GENERAL INTRODUCTION 
 
Dissertation Organization 
    The manuscript-based format is used in my dissertation with the inclusion of three 
papers. The main body consists of one paper published in Biochemical Journal, a second 
paper published in Experimental Cell Research, and a third manuscript that will be submitted 
for publication in the journal Molecular Biology of the Cell. I was responsible for the design, 
implementation, and interpretation of almost all of the experiments in these three papers. I 
did receive initial help and guidance from Rahul Bhosle, a previous graduate student in our 
lab, and from Dr. Susan Veneziano, a postdoctoral assistant in the lab. Dr. Denise Paulin and 
Dr. Zhenlin Li at the University of Paris provided the full-length human synemin cDNAs 
used in my research. The references cited in the literature review are in the format of 
author/year style for ease of reading. Those references cited in the manuscripts are formatted 
in the styles according to the requirements of each journal and are listed in separate 
Reference sections corresponding with each manuscript. A comprehensive list of references 
with article titles is included at the end of the dissertation following the GENERAL 
CONCLUSIONS section. 
 
Introduction 
The overall goal of the research described in this dissertation was to increase our 
understanding of the cellular functions of the two large isoforms of the mammalian type VI 
intermediate filament (IF) protein synemin. It is generally known that the ~310 amino acid 
conserved central rod domain of cytoplasmic IF proteins mediates IF protein assembly by 
forming “coiled-coil” structures, whereas the head and tail domains of IF proteins contain 
most of the binding sites for non-IF protein partners. Thus, the unusually large C-terminal 
tails (933 amino acids in β-synemin and 1245 amino acids in α-synemin) of the mammalian 
(human) synemins likely contain most of the binding sites for their non-IF protein partners. 
Indeed, previous studies in our lab demonstrated that the long C-terminal tail domain of avian 
synemin, which is expressed as only one form, was shown to interact with α-actinin and 
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vinculin.  
Avian synemin shares only ~35% sequence identity and ~53% sequence homology with 
the human synemin isoforms. Whether either of the two human synemin isoforms interact 
with vinculin has not been known. Furthermore, whether either synemin isoform interacts 
with metavinculin, which is a muscle specific isoform of vinculin, has also been unknown. 
The first manuscript (published in Biochemical Journal) included in this dissertation 
describes molecular interaction studies of the human α- and β- synemin isoforms with 
vinculin and metavinculin. The results demonstrate that the 312 amino acid insert (SNTIII), 
which is present only within α-synemin, interacts specifically with both vinculin and 
metavinculin, whereas regions from human β-synemin do not. Uyama et al. (2006, Gut 
55:1276-1289) recently reported that synemin co-precipitates and co-localizes with talin, 
which is another key cytoskeletal protein regulating focal adhesion dynamics. However, 
information demonstrating direct interaction of synemin with talin has been unclear. The 
second manuscript (published in Experimental Cell Research) included in this dissertation 
demonstrates that SNTIII present in α-synemin, but not in human β-synemin, interacts 
specifically with the talin rod domain. Furthermore, SNTIII was found to be composed of 
seven ~39 amino acid tandem repeats. These studies in toto demonstrate that it is the human 
α-synemin isoform that interacts with vinculin and talin, thereby exhibiting functions not 
present within the smaller β-synemin isoform.  
To increase our understanding of the role(s) of the smaller β-synemin, yeast two-hybrid 
screening of a human adult skeletal muscle cDNA library, using the entire tail domain of 
human β-synemin as the bait, was performed. These studies are described in the third 
manuscript included in this dissertation. The protein zyxin, an adhesion plaque protein, was 
discovered to be a novel interaction partner for both human α- and β-synemins. Subsequent 
interaction studies mapped the binding site for synemin within zyxin and the sites for zyxin 
within the synemins. By using siRNA studies, potential functions for synemin in cell 
adhesion and migration are also described in the third manuscript. 
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Review of Literature 
Intermediate Filament Proteins 
There are three major filamentous cytoskeletal components present within cytoskeletons 
of mammalian cells, namely the microfilaments composed primarily of actin monomers, the 
microtubules composed primarily of α- and β-tubulins, and the intermediate filaments (IFs) 
comprising cell-type specific intermediate filament (IF) proteins (Robson, 1989; Fuchs and 
Weber, 1994). These three cytoskeletal components constitute an intricate three-dimensional 
network within the cytoplasm and the nucleus, and contribute to many important biological 
events occurring within eukaryotic cells. As for microfilaments and microtubules, research on 
IFs has long been of a focus of interest to many investigators. The name of IFs came from 
their ~10 nm diameter, which is intermediate between that of microfilaments (6 nm) and 
microtubules (23 nm) (Ishikawa et al., 1968). In contrast to microfilaments and microtubules, 
which are polar filaments composed of highly conserved globular monomers, IFs are 
composed of elongated IF protein subunits having no any obvious polarity (Strelkov et al., 
2003). To date, at least 67 IF genes encoding individual IF proteins have been identified in 
the human genome (Hesse et al., 2001). The nucleotide sequences of these IF genes are 
highly diverse, and the proteins they encode are also diversely expressed in various tissues 
with different abundance (Fuchs and Cleveland, 1998). Nonetheless, all the IF proteins share 
a characteristic tripartite structural feature, namely a centrally conserved ~310 amino acid rod 
domain flanked by hypervariable head and tail domains (Coulombe et al., 2001). The 
conserved rod domain is composed primarily of α-helical segments and is essential in 
mediating coiled-coil dimer formation as well as IF protein assembly (Strelkov et al., 2003; 
Herrmann and Aebi, 2004; Kreplak et al., 2004). The hypervariable head and tail domains, 
having various lengths and primary sequences, contribute to the diversity among the 
individual IF proteins (Coulombe and Wong, 2004), and may harbor most of the binding sites 
for their non-IF protein partners (Green and Simpson, 2007; Kim and Coulombe, 2007).  
Intermediate filament proteins are classified into six major types based upon the 
nucleotide sequence homology within their rod domains (Coulombe et al., 2001). The acidic 
and basic keratins constitute the type I and type II IF proteins, respectively, and they usually 
form obligate heteropolymers upon IF formation (Herrmann and Aebi, 2004; Omary et al., 
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2004). The type III IF proteins consist of desmin, vimentin, glial fibrillary acidic protein 
(GFAP) and peripherin. These are able to self-assemble into homopolymeric 10 nm diameter 
IF filaments, but usually form heteropolymers with other IF proteins (Ivaska et al., 2007). 
The neurofilament triplet proteins (NF-L, NF-M, NF-H) and α-internexin, which are 
expressed in neurons, constitute the type IV IF proteins (Coulombe et al., 2001). The type V 
IF proteins comprise the nuclear lamins that form the nuclear lamina located along the inner 
surface of the nuclear envelope (Wilson et al., 2001). Notably, the lamins can not form 
heteropolymers with the cytoplasmic IFs, possibly because of an extra 41 amino acid insert 
present within the lamin rod domain (Herrmann et al., 2000). Synemin and nestin constitute 
the type VI IF proteins, both of which contain an extremely short N-terminal head domain 
and a very long C-terminal tail domain. In contrast to the type III IF proteins, synemin and 
nestin are unable to self-assemble into homopolymeric IFs, but they do form heteropolymeric 
IFs with desmin and/or vimentin (Robson et al., 2004). 
One of the most commonly recognized functions of all the IFs is that they provide 
mechanical structural support in living cells (Fuchs and Weber, 1994). A canonical example 
is that mutations in keratins K5 and K14, which are expressed within stratified dermal 
epithelium, causes Epidermolysis Bullosa Simplex, a severe skin blistering disease (Fuchs et 
al., 1994). Keratin K6 knockout neonatal mice also exhibit damaged cellular integrity of 
dorsal tongue epithelium after suckling from their mother (Wong et al., 2000). Novel 
functions of IFs have been emerging in recent years. Many studies have shown that IFs play 
essential roles in regulating cell adhesion and migration, apoptosis, protein and lipid targeting, 
and in organizing subcellular organelles such as mitochondria (Kim and Coulombe, 2007). 
Possible functions of IFs in cell adhesion and cell motility are focused upon herein this 
review of literature. 
 
IFs in cell adhesion and migration 
    It has long been known that cytoplasmic IFs are attached at sites of desmosomes and 
hemidesmosomes within stratified and complex epithelia (Kottke et al., 2006; Litjens et al., 
2006). Desmosomes are important cell-cell junctions that maintain the tissue integrity of 
epithelia and cardiac muscle cells (Green and Simpson, 2007), whereas hemidesmosomes 
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contribute to epithelial cell-extracellular basement membrane adhesions (Jones et al., 1998).  
The major protein components that assemble desmosomes are cadherin-family proteins, 
armadillo proteins, and plakins. The transmembrane cadherins, desmogleins and 
desmocollins, establish the interface of desmosomes and bind to the armadillo proteins 
plakoglobins and plakophilins (Green and Simpson, 2007). Armadillo proteins, in turn, 
interact with the plakin family members, desmoplakins, which provide a platform for linking 
the IFs to desmosomes (Hatsell and Cowin, 2001). The desmoplakins bind specifically to the 
rod domains of the IF proteins keratin, vimentin, and desmin via the C-terminal plakin repeat 
domains (Fontao et al., 2003). Knockout animal models of, or mutations in, the desmoplakins 
resulted in disrupted desmosomes and defects in embryonic development, as well as tissue 
integrities of skin and cardiac muscles (Kottke et al., 2006; Green and Simpson, 2007). In 
hemidesmosomes, integrin α6β4, collagen family member BP180, CD151, and two plakin 
family members plectin and BP230 are the major constituents (Litjens et al., 2006). Integrin 
α6β4 contributes to the stable attachment of epithelial cells to the basement membrane via 
interactions with laminin-332, a major extracellular matrix protein expressed in the basement 
membrane (Wilhelmsen et al., 2006). Intermediate filament proteins are linked to 
hemidesmosomes via interactions with the C-terminal plakin repeats of plectin and BP230, 
which interacts with integrin β4 (Koster et al., 2004). Disruption of hemidesmosomes leads 
to a spectrum of skin blistering phenotypes, indicating they are essential for maintaining 
epidermal tissue integrity (Zillikens, 1999). Some studies have also indicated that, during cell 
migration and cancer cell invasion, hemidesmosomes are disassembled and redistributed 
(Wilhelmsen et al., 2006). Thus, hemidesmosomes are not only important for cell-stromal 
membrane attachment, but also are associated with cell motility. 
Accumulating evidence has shown that IFs can also be anchored at the classical cell-cell 
and cell-extracellular matrix adherens-type junctions (Kim and Coulombe, 2007). Kowalczyk 
et al. reported that desmoplakins were recruited to cell-cell adherens-type junctions along 
with VE-cadherin, and thereby may be able to link IFs to these sites (Kowalczyk et al., 1998). 
The type III IF protein vimentin was also shown to co-precipitate and co-localize with p120 
catenin, which is another component of the cell-cell adherens-type junctions (Kim et al., 
2005). In addition, fluorescent protein-tagged vimentin was shown to partially overlap with 
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integrin β3 within endothelial cells at the focal adhesions sites, which represent 
cell-substratum adherens-type junctions of cultured cells (Tsuruta and Jones, 2003). Another 
study also reported that, using leucine zipper mediated recombinant integrin α2β1 
heterodimers, vimentin was found to interact with the α2β1 dimer in screening assays for 
putative binding partners. And, vimentin transiently co-localized with integrin α2β1 at the 
focal adhesion sites within endothelial cells (Kreis et al., 2005). Knockdown vimentin 
expression using RNAi led to smaller focal adhesions and decreased adhesions of endothelial 
cells upon shear stress (Tsuruta and Jones, 2003). These studies suggest that vimentin IFs 
contribute significantly to cell-substratum adhesions and regulate focal adhesion sizes.  
The large type VI IF proteins nestin and synemin have also been shown to play essential 
roles in cell adhesion and migration. A recent study (Kleeberger et al., 2007) showed that 
nestin was up-regulated in several prostate cancer cell lines capable of metastases. RNAi 
studies showed that nestin knockdown markedly impaired prostate cancer cell metastasis and 
invasion, suggesting that nestin plays a role in regulating cell motility (Kleeberger et al., 
2007). Studies done in our lab have also demonstrated interactions of synemin with vinculin, 
α-actinin, and dystrophin/utrophin within vertebrate muscle cells, suggesting that synemin is 
able to attach to adhesion sites enriched in these cytoskeletal proteins (Bellin et al., 1999; 
Bellin et al., 2001; Bhosle et al., 2006). 
 
Synemin 
The type VI IF protein synemin is a very large, unique member of the IF protein 
superfamily (Robson et al., 2004). Synemin was first discovered within avian smooth and 
skeletal muscle cells where it associates with the major type III IF proteins desmin and 
vimentin (Granger and Lazarides, 1980). It was at that time classified as an intermediate 
filament-associated protein (IFAP). Cloning and sequencing studies in our lab subsequently 
demonstrated that synemin is a bona fide IF protein containing the conserved characteristic 
IF protein rod domain (Becker et al., 1995). Sequencing studies of avian synemin in our lab 
indicated that it exhibits a very short, 10 amino acid head domain and a very long, more than 
1,000 amino acid tail domain (Bellin et al., 1999). Results from our lab also demonstrated 
synemin is expressed within mammalian muscle tissues. Western blot analysis of porcine 
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muscle tissues using anti-avian synemin antibodies resulted in two bands at molecular 
weights of ~225 KDa and ~195 KDa (Bilak et al., 1998). Titeux et al. subsequently cloned 
and sequenced the human synemin gene and showed that it encodes two large splice variants, 
namely α-synemin (~180 KDa) and β-synemin (~150 KDa). Both α- and β-synemins 
co-localize with desmin and vimentin within muscle cells (Titeux et al., 2001). The mouse 
synemin gene was also cloned and sequenced recently and shown to encode three isoforms, 
namely H, M, and L-synemins, resulting from alternative splicing (Xue et al., 2004). 
    Although synemin is primarily expressed in muscle tissues, it is also expressed in many 
non-muscle tissues and cells. For example, synemin is found present within avian 
erythrocytes (Granger et al., 1982) and lens cells (Granger and Lazarides, 1984), rat and 
human astrocytes (Sultana et al., 2000; Jing et al., 2005), human glial cells and neurons 
(Hirako et al., 2003; Izmiryan et al., 2006), human retina and lens cells (Tawk et al., 2003), 
and in human hepatic stellate cells (Uyama et al., 2006). Also, there are accumulating reports 
of synemin expression in malignant cancer cells. These include human adrenal cortex 
adenocarcinoma cells (SW13 cells) (Bellin et al., 1999), hepatoma cells (HepG2 and J-5 cells) 
(Chan et al., 2007), malignant astrocytes (Jing et al., 2005), cervix epithelial adenocarcinoma 
cells (Hela cells) (Olsen et al., 2006), and malignant biliary epithelial cells (Schmitt-Graeff et 
al., 2006). The wide expression of synemin in various tissues and cancer cells suggests 
synemin has important cellular functions. 
    Avian and mammalian synemins are not able to assemble into homopolymeric IFs in 
vivo, but associate with other IF proteins such as vimentin, desmin, and neurofilament 
proteins forming heteropolymeric IFs (Bellin et al., 1999; Titeux et al., 2001; Xue et al., 
2004; Izmiryan et al., 2006; Jing et al., 2007). Results from our lab indicated that the 
association is mediated by interactions between the conserved rod domain of synemin and 
those of desmin and/or vimentin (Bellin et al., 1999). We have also shown that the C-terminal 
tail domain of avian synemin interacts with the cytoskeletal proteins α-actinin and vinculin 
by blot overlay assays (Bellin et al., 1999; Bellin et al., 2001). Subsequent interaction studies 
in our lab using recombinant proteins of avian and human synemin regions and of 
dystrophin/utrophin regions showed that the tail domain of synemin binds to the cysteine rich 
region and specific spectrin-like repeat region within both dystrophin and utrophin (Bhosle et 
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al., 2006). Studies by Mizuno et al. (2001) demonstrated that the human synemin rod domain 
binds to α-dystrobrevin, a component of the dystrophin-associated protein complex that 
interacts directly with dystrophin (Mizuno et al., 2001). In mdx mice having no dystrophin, 
synemin mRNA expression was also found to be decreased (Mizuno et al., 2007). 
Interestingly, α-actinin, vinculin, dystrophin, and α-dystrobrevin are all present in cell 
adhesion sites such as the costameres within muscle cells. Costameres are multi-protein 
assemblies considered to be specialized cell-substratum adherens-type junction sites in 
register with the peripheral layer of cellular myofibrillar Z-lines, and are present periodically 
along and immediately subjacent to the sarcolemma (Craig and Pardo, 1983; Pardo et al., 
1983). It is believed that forces generated by contracting myofibrils within a muscle cell are 
laterally transmitted to the extracellular matrix via the costameres (Ervasti, 2003). Therefore, 
synemin appears able to link the heteropolymeric IFs to the adhesion sites such as costameres 
within vertebrate striated muscle cells. Indeed, synemin has been shown to be enriched at the 
costameres and neuromuscular and myotendinous junctions within human skeletal muscle 
cells (Mizuno et al., 2004). Thus, it is evident that the synemin and desmin/vimentin 
heteropolymeric IFs encircle each myofibril at its Z-lines, thereby linking all adjacent 
myofibrils within the striated muscle cell, and linking the lateral outermost layer of 
myofibrils to the adhesion sites subjacent to sarcolemma. These linkages thereby contribute 
to maintaining the structural and functional integrity of the contracting myofibers.  
    Several studies from other labs working on synemin have provided information about 
other putative cellular functions of synemin. Jing et al. reported in a recent study that 
α-synemin was highly expressed in astrocytic tumors, and that both α- and β-synemins were 
newly synthesized by reactive and neoplastic astrocytes within human brain tissue (Jing et al., 
2005). These authors also demonstrated that synemin co-localized with α-actinin within the 
membrane ruffles of glioblastoma cells, suggesting synemin may play a role in cell motility 
(Jing et al., 2005). Russell et al. reported that synemin interacts with protein kinase A (PKA) 
within human cardiac muscle cells, and suggested that synemin is an A-kinase anchoring 
protein (AKAP) providing temporal and spatial targeting of PKA (Russell et al., 2006). 
Schmitt-Graeff et al. showed that synemin expression was widespread in liver cell fibrosis 
and was up-regulated in malignant liver cells, indicating that synemin may be involved in 
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these disease processes (Schmitt-Graeff et al., 2006). However, a synemin knockout model, 
either in cells or animals, has not yet been established, and all of the exact overall cellular 
functions of synemin remain to be clarified. 
 
Vinculin and metavinculin 
    Vinculin is a ubiquitously expressed important cytoskeletal protein present at the 
cytoplasmic face of cell-cell and cell-extracellular matrix adherens-type junctions (Demali, 
2004; Ziegler et al., 2006). The 116 KDa vinculin molecule is composed of an ~90 KDa head 
domain, an ~27 KDa tail domain, and a proline rich linker region containing binding sites for 
SH3 domains (Bakolitsa et al., 1999). A recent report showed that vinculin actually exhibits 
an overall three dimensional “bundle of bundles” structure comprising five domains (D) of 
α-helical bundles (Bakolitsa et al., 2004). The N-terminal ~90 KDa head domain comprises 
four of the five domains (D1-D4) and the C-terminal ~27 KDa tail domain is the fifth domain 
itself (D5), with the loop-like proline rich linker region connecting the head and tail domains 
(Bakolitsa et al., 2004). Vinculin contains binding sites for many protein partners that are 
also present within adherens junctions, and thus it is believed to serve as an adapter for 
multi-protein assembly within adherens junctions (Jockusch and Rudiger, 1996; Critchley, 
2000). For examples, the vinculin head domain contains binding sites for talin, α-catenin, 
and α-actinin, the tail domain binds to paxillin and F-actin, and the proline rich linker region 
between the head and tail domains harbors binding sites for vinexin, vasodilator stimulated 
phosphoprotein (VASP), and the ARP2/3 complex (Critchley, 2000; Ziegler et al., 2006). 
However, vinculin is usually held in an autoinhibited state by the intramolecular association 
between the head and the tail domains in the cytoplasm, which abolishes most of the 
interactions of the protein partners with vinculin (Johnson and Craig, 1995). When recruited 
to adhesion sites, vinculin is activated, which means that the head and the tail association is 
disrupted (Chen et al., 2005). Activation of vinculin is thought to be induced in a 
combinatory pathway by simultaneous binding of two or more partners (Bakolitsa et al., 
2004), which exposes all of the binding sites for protein partners and recruits multiple 
proteins thereby forming complicated adhesion complexes. The role of vinculin in regulating 
cell adhesion and migration is illustrated by studies using vinculin-null cells. The latter cells 
 10
exhibited smaller focal adhesion sites, and closed wound more rapidly in comparison to wild 
type vinculin positive cells (Saunders et al., 2006). Especially when the vinculin head 
domains bind to talin, another important cytoskeletal protein regulating focal adhesions, they 
promote the recruitment and activation of integrins at focal adhesion sites (Humphries et al., 
2007). Vinculin has also been shown to transiently recruit Arp2/3 to the far end of 
lamellipodia, thereby coupling cell adhesion with cell movement (DeMali and Burridge, 
2003). As shown in (Xu et al., 1998), vinculin knockout mice died at E.10 and exhibited 
heart and brain defects during development, suggesting vinculin is also essential for 
embryonic development.  
    Vinculin has a splice variant, namely metavinculin, that is specifically expressed within 
muscle tissues (Belkin et al., 1988). The only difference between vinculin and metavinculin 
is that metavinculin contains an additional 68 amino acid insert within the C-terminal tail 
domain (Byrne et al., 1992; Koteliansky et al., 1992). Both vinculin and metavinculin are 
present within costameres, intercalated discs, and dense bodies in muscle cells (Witt et al., 
2004). Witt et al. also implicated the additional 68 amino acid insert interferes with the 
activation of the metavinculin molecule. The activities of metavinculin in bundling F-actin 
are also deferent from those of vinculin (Rudiger et al., 1998). We have shown that avian 
synemin interacts with the protein vinculin (Bellin et al., 2001). However, the interaction of 
both vinculin and metavinculin splice variants with mammalian synemin isoforms has 
remained unknown. 
 
Talin 
    Talin is a very large (~230 KDa), elongated cytoskeletal protein present primarily in 
cell-substratum adherens junctions. Previous studies showed that talin is present within the 
costameres, neuromuscular junctions, and myotendinous junctions within mammalian muscle 
cells (Belkin et al., 1986; Sealock et al., 1986; Tidball et al., 1986). It is widely believed that 
talin plays a key role in regulating cell-extracellular matrix adhesions by coupling integrin 
adhesion molecules to the actin cytoskeleton at the cytoplasmic face (Critchley, 2005). Upon 
calpain digestion, talin can be cleaved into a ~47 KDa globular head domain and a ~190 KDa 
elongated rod domain (Hayashi et al., 1999). The talin head domain contains multiple basic 
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amino acids and hence serves as a very good surface for binding of the phospholipids, such 
as phosphatidylinositol-4, 5-bisphosphate (PIP2) (Rees et al., 1990). The talin head domain 
also contains a 4.1-ezrin-radixin-moesin homology (FERM) domain that interacts with 
F-actin (Lee et al., 2004), the β-integrin cytoplasmic domain (Garcia-Alvarez et al., 2003), 
focal adhesion kinase (FAK) (Borowsky and Hynes, 1998), and PIP kinase type-1γ (Di Paolo 
et al., 2002; Ling et al., 2002). The elongated tail domain contains another conserved F-actin 
binding domain (Tremuth et al., 2004) and multiple vinculin binding sites (Gingras et al., 
2006). Thus, talin has been proposed to serve as an adaptor protein mediating multiple 
cytoskeletal protein interactions in focal adhesion assembly (Critchley, 2004; Nayal et al., 
2004). The role of talin in focal adhesion dynamics has been demonstrated by talin knockout 
studies in cultured cells, which showed that down regulation of talin by antisense RNAs 
within cells led to inhibited focal adhesion assembly and cell spreading (Albiges-Rizo et al., 
1995). Talin has also been shown to be indispensable for embryonic development because 
talin-null mice died at around E.9 and exhibited arrested gastrulation at around E.7 (Monkley 
et al., 2000). A recent study reported that human synemin co-localized with talin within 
cultured human hepatic stellate cells, and co-precipitated with talin from the cell extracts 
(Uyama et al., 2006). The latter suggests that synemin associates with talin within the same 
immunocomplex within cells. However, direct interaction of mammalian synemin isoforms 
with talin remains to be explored. 
 
Zyxin 
Zyxin is another protein present at cell-substratum attachments, such as the focal 
adhesions in cultured cells (Crawford and Beckerle, 1991). Western blotting analysis studies 
indicated that zyxin is highly expressed in heart, lung, and smooth muscle tissues, such as the 
small intestines (Macalma et al., 1996). The zyxin molecule is composed of an N-terminal 
proline rich region and a C-terminal region containing three tandem repeats of the LIM 
domains (Sadler et al., 1992). The LIM domain is a tandem zinc-finger structure present in 
many cytoskeletal proteins within the cytoplasm and in transcription factors within the 
nucleus (Kadrmas and Beckerle, 2004). The term of LIM was derived from the first letter of 
three proteins Lin-11, Isl1, and Mec-3, all of which are homeodomain proteins containing a 
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similar cysteine-rich sequence motif (the LIM domain) (Michelsen et al., 1993). It is now 
recognized that the LIM domains mediate important protein-protein interactions, thereby 
recruiting protein partners to specific subcellular locations and modulating their activities 
(Kadrmas and Beckerle, 2004). The LIM region of zyxin is necessary and sufficient to direct 
zyxin to focal adhesion sites (Nix et al., 2001), and it contains binding sites for several 
proteins such as cysteine-rich protein-1 (Schmeichel and Beckerle, 1994) and p130cas (Yi et 
al., 2002). Within the N-terminus of zyxin, it has been shown that the proline rich region 
resembles the proline rich repeats present in the Listeria monocytogenes ActA protein 
(Golsteyn et al., 1997), which facilitate the actin assembly required for Listeria movement in 
the hosts. The ActA repeat within zyxin interacts with the Ena/VASP protein family members 
and is indispensable for appropriate localization of Ena/VASP within focal adhesions (Drees 
et al., 2000). The N-terminus of zyxin also contains a binding site for the cytoskeletal protein 
α-actinin (Crawford et al., 1992; Drees et al., 1999; Li and Trueb, 2001). This latter 
interaction also contributes to directing zyxin to the focal adhesions and actin cytoskeletons 
within cells (Reinhard et al., 1999).  
    Interestingly, zyxin knockout mice exhibit normal development and activities after birth, 
without any defects within several examined tissues (Hoffman et al., 2003). In contrast, 
fibroblasts isolated from zyxin-null mice showed enhanced integrin-dependent adhesion, 
elevated cell migration, and mislocalization of the mena/VASP proteins (Hoffman et al., 
2006). Applying unidirectional cyclic stretch or shear stress to fibroblast cells resulted in 
mobilization of zyxin from the focal adhesions to the actin stress fibers (Yoshigi et al., 2005). 
These latter studies indicate that zyxin is involved in actin remodeling and in regulation of 
cell motility. An additional interesting property of zyxin is that it is able to shuttle between 
the nucleus and the focal adhesions (Nix and Beckerle, 1997; Nix et al., 2001), suggesting 
that zyxin may help in relaying signals between these two sites within cells. Indeed, a recent 
study demonstrated that zyxin functions within the nucleus and interacts with the 
homeodomain transcription factor Xanf1/Hesx1, and modulates its activity in the anterior 
neural plate of the Xenopus laevis embryo (Martynova et al., 2008).  
    Recent studies have been focused on the possible function of zyxin in regulating the 
actin cytoskeleton. There have been no reports on the role of zyxin in modulating IFs within 
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mammalian cells. Furthermore, reports of direct interaction of IF proteins with protein 
components of conventional adhesions sites are limited, and thus, whether IFs join in the 
dynamics of adhesion sites, especially focal adhesions, remains unclear. Studies included in 
my dissertation provide evidence of direct interactions of synemin with vinculin, talin and 
zyxin, all of which are proteins present within conventional cell-cell and cell-substratum 
adherens junctions. Therefore, synemin appears to be a unique IF protein that specifically 
participates in the dynamics of conventional adhesion sites, and may functionally link the 
heteropolymeric IFs to these sites. With regard to muscle cells, synemin isoforms likely link 
the heteropolymeric IFs to adhesion sites such as the costameres, dense bodies/dense plaques, 
neuromuscular junctions, and myotendinous junctions, thereby helping to provide overall 
integration of the muscle cell cytoskeleton. Studies in this dissertation also provide evidence 
that the mammalian synemin isoforms interact differentially with vinculin and talin, 
indicating the mammalian synemin isoforms may have differential functions within 
mammalian cells. In addition, identification of interactions of mammalian synemin isoforms 
with zyxin not only broadens our knowledge of the cellular function of mammalian synemins, 
but also may open a new field of research on the role of zyxin in modulating IF 
cytoskeletons.  
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HUMAN α-SYNEMIN INTERACTS DIRECTLY WITH VINCULIN AND 
METAVINCULIN 
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SYNOPSIS 
Synemin is a very large, unique member of the intermediate filament (IF) protein 
superfamily. Association of synemin with the major IF proteins, desmin and/or vimentin, 
within muscle cells forms heteropolymeric IFs. We have previously identified 
interactions of avian synemin with α-actinin and vinculin. Avian synemin, however, is 
expressed as only one form, whereas human synemin is expressed as two major splice 
variants, namely α- and β-synemins. The larger α-synemin contains an additional 312 
amino acid insert (SNTIII) located near the end of the long C-terminal tail domain. 
Whether α- and β-synemins have different cellular functions has been unclear. In this 
study we show, by in vitro protein-protein interaction assays, that SNTIII interacts 
directly with both vinculin and metavinculin. Furthermore, SNTIII interacts with 
vinculin in vivo, and this association is promoted by 
phosphatidylinositol-4,5-bisphosphate. SNTIII also specifically colocalizes with vinculin 
within focal adhesions when transiently expressed in mammalian cells. In contrast, 
other regions of synemin show distinct localization patterns in comparison to those of 
SNTIII, without labeling focal adhesions. Our results indicate α-synemin, but not 
β-synemin, interacts with both vinculin and metavinculin, thereby linking the 
heteropolymeric IFs to adhesion-type junctions, such as the costameres located within 
human striated muscle cells. 
 
Key words: intermediate filaments, synemin, vinculin, metavinculin, costameres, focal 
adhesions 
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INTRODUCTION 
Intermediate filaments (IFs) are very long, ~10-nm diameter, filamentous components that 
function in general as mechanical integrators of cellular space [1]. They help maintain both 
the morphology and integrity of animal cells [2]. Different types of IFs are composed of 
cell-type specific intermediate filament (IF) proteins that, in turn, give rise to the distinct 
properties of the filaments they form [3, 4]. There are more than 65 IF genes encoding 
distinct IF proteins within the human genome [5]. All of the IF proteins share a common 
tripartite structural feature, with a central ~310 amino acid conserved rod domain, flanked by 
hypervariable N-terminal head and C-terminal tail domains [4, 6-8].  
Synemin is a very large, unique type VI member of the IF protein superfamily [9]. It is 
expressed in all three types (skeletal, cardiac, and smooth) of muscle cells [9-11], as well as 
in some specific non-muscle tissues and cells [10, 12-18]. The human synemin gene encodes 
two major isoforms, named α-synemin (180 kDa by SDS-PAGE; 172.7 kDa from sequence) 
and β-synemin (150 kDa by SDS-PAGE; 140.1 kDa from sequence), which are generated by 
alternative splicing [19]. The larger α-synemin contains an additional, unique 312 amino acid 
insert located near the end of the long C-terminal tail domain. This insert is absent in and not 
homologous to any of the sequence within the smaller β-synemin isoform [19]. In contrast to 
the α- and β- human synemin isoforms, avian synemin is expressed in only one form, which 
is considered the ortholog of human α-synemin. Interestingly, avian synemin and human α- 
and β-synemins all fail to assemble into homopolymeric filaments in cells, requiring the 
presence of the type III IF protein desmin and/or vimentin to form heteropolymeric IFs [19, 
20].  
Several proteins have been identified that interact with synemin. It was previously shown 
that the rod domain of both avian [20] and human [21] synemin interacts directly with 
desmin. The human synemin rod domain also interacts with α-dystrobrevin [21], and 
dystrophin and utrophin [22]. The avian synemin tail domain was originally shown to interact 
with vinculin and α-actinin [23]. Also, a fragment within the human α-synemin tail domain, 
sharing part of the β-synemin tail sequence, was reported to bind to dystrophin and utrophin 
[22]. Interestingly, the proteins found to interact with the synemin tail domain are all 
actin-binding proteins known to be present within myofibrils and/or within the costameric 
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structures located in striated muscle cells. The costameres represent specialized focal 
adhesion-type structures located periodically along and immediately subjacent to the 
sarcolemma [24-26]. Those findings, taken in toto, suggest that one of the functions of 
synemin is to link the heteropolymeric IFs to the sarcolemma.  
Because avian synemin shares very low sequence identity (~35%) with the human 
synemins, and considering that the human synemin gene generates two major isoforms 
(α and β), resulting in differing lengths of their tail domains, the protein interactions of 
human and avian synemins may differ. Thus, it is important to characterize interactions of the 
human synemin isoforms with those proteins previously shown to bind to the avian synemin 
tail domain. Most importantly, these studies will help ascertain whether the two human 
synemin isoforms have different functions.  
The major purpose of this study was to identify and clarify the interactions of human α- 
and β-synemins with both vinculin and its muscle-specific isoform, metavinculin. The 
cytoskeletal protein vinculin is a major component of cell-cell and cell–extracellular matrix 
adhesion junctions [27-29]. It is composed of a 90 kDa N-terminal head domain (VH), a 
proline rich linker, and a 27 kDa C-terminal tail domain (VT) [30]. Metavinculin contains an 
additional 68 amino acid insert within the tail domain [31, 32]. It was originally shown that 
the VT interacts with avian synemin [23]. Whether there are interactions between the 
metavinculin tail domain (MVT) and human synemin isoforms has been unknown. 
Preliminary studies in our lab showed no interactions of human β-synemin with vinculin and 
metavinculin. We hypothesize that the unique 312 amino acid insert within α-synemin 
contains the binding site for vinculin and metavinculin, and therefore confers extra functions 
to α-synemin. We show herein that the specific 312 amino acid sequence present within the 
tail domain of human α-synemin, which is absent in β-synemin, interacts directly with the 
tail domains of both human vinculin and metavinculin. Taken in toto, our results indicate that 
α- and β-synemins have different functions within muscle cells. Based upon its direct 
interaction with vinculin and metavinculin, human α-synemin appears able to link the 
heteropolymeric IFs to adhesion-type junctions such as the costameres within striated muscle 
cells, thereby fulfilling an overall very important cytoskeletal role within the muscle cell 
cytoskeleton. 
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MATERIALS and METHODS 
Generation of cDNA constructs 
The full-length human α- and β-synemin cDNAs, which served as the templates for 
amplifying all of the human synemin regions by polymerase chain reaction (PCR), were 
described previously [22]. All primers used for PCR were synthesized at the DNA 
Sequencing and Synthesis Facility, Iowa State University (Ames, IA). cDNAs encoding 
human synemin tail (T) fragments (SNTIa, residues 321-579; SNTIb, residues 580-920; 
SNTIII, residues 1151-1462; and SNβTII, residues 921-1251) were amplified by PCR using 
appropriate primer pairs, and subsequently cloned into pFLAG-ATS expression vectors 
(Sigma, St. Louis, MO) at 5’ Hind III and 3’ Bgl II sites as FLAG-tagged constructs. In order 
to increase solubility of the SNTless region (residues 1-329), it was cloned into pMAL-C2X 
maltose binding protein (MBP) expression vector (New England Biolabs, Ipswich, MA) at 5’ 
EcoR I and 3’ Sal I sites as a MBP-tagged fusion protein (MBP-SNTless).  
The SNTIII region was subsequently divided into three consecutive sub-fragments named 
SNTIIIa (residues 1151-1243), SNTIIIb (residues 1244-1358), and SNTIIIc (residues 
1359-1462). The three sub-fragments and the full-length SNTIII were PCR amplified using 
appropriate primer pairs containing 5’ BamH I and 3’ Hind III sites, and subsequently cloned 
into pMAL-C2X vectors as MBP-tagged proteins.  
SNTIII was also PCR amplified and subcloned into the pEGFPc3, enhanced green 
fluorescent protein (EGFP) expression vector (BD Biosciences, San Jose, CA), at 5’ Hind 
III and 3’ BamH I sites. SNTless cDNA was digested out of the MBP-SNTless construct at 
the sites of 5’ EcoR I and 3’ Sal I and then inserted into the pEGFPc2 vector (BD 
Biosciences). The full-length human β-synemin tail domain (SNβT, residues 321-1251) was 
PCR amplified and subsequently cloned into the pEGFPc3 vector at 5’ Hind III and 3’ 
BamH I sites. 
The cDNAs of the human vinculin tail (VT, residues 877-1066) and metavinculin tail 
(MVT, residues 877-1134) were amplified by reverse transcriptase-PCR from the Human 
Skeletal Muscle Total RNA Library (BD Biosciences). The amplified VT and MVT cDNAs 
were then cloned into the pGEX-4T2 glutathione S-transferase (GST) expression vector (GE 
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Healthcare, Pittsburgh, PA) at 5’ BamH I and 3’ Xho I sites.  
Accuracy of all constructs was confirmed by automated sequencing in the DNA 
Sequencing and Synthesis Facility at Iowa State University. 
 
Expression and purification of recombinant proteins 
Each expression construct was transformed into E.coli BL21-Codon Plus (DE3) bacterial 
cells (Stratagene, La Jolla, CA). Protein expression was induced by 
Isopropyl-beta-D-thiogalactopyranoside (IPTG). FLAG-tagged synemin fusion proteins were 
purified by affinity chromatography using Anti-FLAG M2-Agarose Affinity Gel (Sigma). 
GST-VT and GST-MVT were batch purified using Glutathione Agarose (sigma). 
MBP-tagged synemin fusion proteins were batch purified or purified by affinity 
chromatography using Amylose Resin (New England Biolabs). 
 
Antibodies 
Anti-synemin 2856 pAb has been described previously [20]. Anti-FLAG polyclonal antibody 
(pAb), anti-vinculin monoclonal antibody (mAb) hVIN-1, anti-desmin mAb DEU-10, 
anti-α-actinin mAb BM7.5, and anti-vimentin mAb V9 were obtained from Sigma. Anti-GST 
mAb, anti-GFP pAb, and horseradish peroxidase (HRP) conjugated anti-GFP pAb were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-MBP pAb and HRP 
conjugated anti-MBP mAb were obtained from New England Biolabs. Alexafluor secondary 
antibodies and Alexafluor-594 phalloidin were obtained from Invitrogen (Carlsbad, CA). 
 
Western blots and blot overlay assays 
Western blots and blot overlay assays were conducted as previously described [20]. For blot 
overlay assays, equal picomoles of purified GST-VT, GST-MVT, bovine serum albumin 
(BSA), and GST were subjected to SDS-PAGE, and then transferred to nitrocellulose 
membranes, with BSA and GST serving as controls. The resulting blot containing the 
respective transferred proteins was overlaid with 10 μg/ml of purified synemin fusion protein 
in PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4), 
containing 0.1% (v/v) Tween-20 and 1% (w/v) non-fat milk powder. As a negative control, a 
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duplicate blot was overlaid with buffer containing no protein. Protein interactions were 
detected with anti-FLAG pAb or anti-MBP serum by chemiluminescence. Densitometric 
analysis from three independent experiments of the blot overlay assays was done using 
Kodak 1D Image Analysis software (Eastman Kodak Company, Rochester, NY). For Western 
blotting using human tissue protein lysates, human adult skeletal muscle and human uterine 
smooth muscle total protein lysates were purchased from Biochain (Hayward, CA). 
 
GST pull-down assays 
Reactions containing 50 μM of each GST fusion protein was incubated with 20 μl bed 
volume of glutathione agarose beads in binding buffer (50 mM Tris, 150 mM NaCl, 0.5% 
Triton-X 100, pH 7.4) for 1 hour at 4°C. Purified synemin fusion protein was then added to 
reach a final concentration of 50 μM and incubated for 12 hours at 4°C. After extensive 
washing with PBS containing 0.2% Tween-20 (PBST), the beads were eluted with 2x SDS 
sample buffer. Eluates were subjected to SDS-PAGE and analyzed by Western blotting with 
anti-FLAG pAb or anti-MBP serum. 
 
Solid phase binding assays by ELISA 
Solid phase binding assays were performed as previously described [33] with minor 
modifications. Assays were all performed in duplicate. Briefly, 96-well microtiter plates 
(Nunc, Rochester, NY) were coated overnight at 4°C with 100 nM purified GST-VT or 
GST-MVT diluted in PBS. Wells were then blocked with PBS containing 1% (w/v) non-fat 
milk powder for 4 hours at 37°C. Series of dilutions of MBP-tagged synemin fusion protein 
or of MBP alone ranging from 800 nM to 0 nM, i.e. buffer only, were then added and 
incubated for 1 hour at 25°C. After extensive washing with PBS containing 0.1% (v/v) 
Tween-20, bound MBP fusion proteins were detected with the HRP conjugated anti-MBP 
mAb and the HRP substrate 2,2'-azino-bis-[3-ethylbenzthiazoline-6-sulfonic acid] (ABTS) 
(Southern Biotechnology, Birmingham, Alabama), by measuring absorbance at 405 nm (A405). 
Data were then analyzed with Microsoft Excel.  
 
Cell culture 
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A-10 cells, a rat aorta vascular smooth muscle cell line, were purchased from American Type 
Culture Collection (ATCC, Manassas, VA). NIH/3T3 cells were kind gifts of Dr. Janice E. 
Buss (Iowa State University). The A-10 cells were maintained with Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 4.5 g/L glucose, 
4 mM L-glutamine, 100 U/ml penicillin G, and 100 U/ml streptomycin at 37°C (95% air, 5% 
CO2). The NIH/3T3 cells were cultured under the same conditions as the A-10 cells, except 
10% calf serum was used in place of 10% FBS in the growth media. 
 
Immunoprecipitation assays 
NIH/3T3 cells were grown to 50% confluence and then transfected with either EGFP-SNTIII 
plasmids, or the EGFP vectors alone, using JetPEI Transfection Reagent (Polyplus 
Transfection, San Marcos, CA). Cells were then lysed using the M-PER Mammalian Cell 
Extraction Buffer (Pierce Biotechnology, Rockford, IL) 24 hours post transfection. The 
resulting cell lysates were then incubated in the presence or absence of 100 μM 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) micelles at 4°C for 20 min. 
PtdIns(4,5)P2 was obtained from Avanti Polar Lipids (Alabaster, AL). The PtdIns(4,5)P2 
micelles were prepared as previously described [34]. The samples were then incubated for 4 
hours at 4°C with anti-GFP pAb coupled to Protein A Agarose (Santa Cruz). After extensive 
washing with PBST, the beads were eluted with 2x SDS sample buffer. The resulting eluates 
were subjected to SDS-PAGE and analyzed by Western blotting with anti-vinculin hVIN-1 
mAb, or HRP conjugated anti-GFP pAb.  
 
Immunofluorescence, confocal microscopy and transfection studies 
Adult human skeletal muscle tissue sections were purchased from Biochain. The tissue 
sections were rinsed with PBS, permeabilized by 0.2% Triton-X 100 in PBS, and blocked 
with 10% BSA in PBS at 25°C. The sections were then incubated with anti-synemin 2856 
pAb plus anti-vinculin mAb hVIN-1, anti-synemin 2856 pAb plus anti-α-acitin mAb BM7.5, 
or with anti-synemin 2856 plus anti-desmin mAb DEU-10, followed by incubation with 
appropriate Alexafluor secondary antibodies. After extensive washing with PBS, the sections 
were mounted with coverslips using Vectashield Mounting Medium (Vector Laboratories, 
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Burlingame, CA). For transfection studies, cells were seeded on collagen-coated coverslips to 
reach approximately 50% confluence. Cells were then transfected with EGFP-tagged 
synemin constructs, or with the EGFP vectors alone, using JetPEI Transfection Reagent. 
Twenty four to thirty six hours post transfection, the cells were fixed, permeabilized, and 
immunostained with anti-GFP pAb plus anti-vinculin hVIN-1, anti-GFP plus anti-vimentin 
mAb V9, or with anti-GFP pAb plus Alexafluor-594 phalloidin following procedures 
described immediately above. Epifluorescence microscopy was conducted using a LEICA 
DEMIRE2 inverted microscope equipped with a CCD camera in the Hybridoma Facility at 
Iowa State University. Confocal microscopy was conducted using a LEICA TCS NT 
Confocal Microscope in the Confocal Microscopy and Image Analysis Facility at Iowa State 
University. 
 
RESULTS 
Mapping the binding sites of vinculin and metavinculin in human synemin 
How the large IF protein synemin contributes to the organization as well as functionality of 
the molecular contractile apparatus within mammalian muscle cells has long been a central 
interest of our studies. In order to examine the putative interactions of human synemin with 
vinculin and metavinculin, and to map the binding site(s) of vinculin and metavinculin within 
human synemin isoforms, polypeptides corresponding to specific regions spanning the entire 
amino acid sequences of human α- and β-synemins were generated as diagrammed in Fig. 
1A. SNTless, SNTIa, SNTIb, and SNβTII are regions shared by both human α-synemin and 
β-synemin, whereas SNTIII is the additional 312 amino acid insert present only in α-synemin. 
Regions covering the C-terminal tail (SNTIa, SNTIb, SNTIII, and synβTII) were all cloned 
as FLAG-tagged fusion proteins. SNTless resulted from deleting the entire long C-terminal 
tail domain, and was expressed as a MBP-tagged fusion protein to increase its solubility 
during purification. These synemin fusion proteins were expressed in bacteria, 
affinity-purified, and analyzed by SDS-PAGE as shown in Fig. 2A. The identities of these 
bands were confirmed by Western blots with anti-FLAG and anti-MBP polyclonal antibody 
(pAb) (data not shown). Human VT and MVT were chosen in this study because we had 
previously determined that only the VT interacts with avian synemin whereas the VH does 
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not [23], and vinculin is highly conserved among different species, i.e. over 95% identity 
[35]. Human VT and MVT were expressed as GST-tagged fusion proteins (Fig. 1B).  
Interactions of specific protein domains of human synemin with human VT and MVT were 
analyzed by blot overlay assays. As shown in Fig. 2B, blots containing purified GST-VT, 
GST-MVT, BSA, and GST were probed with each purified synemin fusion protein. Specific 
interactions of the synemin fusion proteins with GST-VT and/or GST-MVT were detected 
with anti-MBP and anti-FLAG pAb. Only SNTIII, which is the 312 amino acid insert present 
in α-synemin but absent in β-synemin, showed interactions with both VT and MVT. None of 
the other synemin fusion proteins showed any detectable interaction with VT or MVT (Fig. 
2B). These results indicate that α-synemin harbors the binding site(s) for both vinculin and 
metavinculin. 
GST pull-down assays were also conducted to examine possible interactions of synemin 
fusion proteins with VT or MVT, and to confirm the results of the blot overlay assays. The 
GST pull-down assays (Fig. 2, C and D) demonstrated that only SNTIII was specifically 
precipitated by both GST-VT (Fig. 2C) and GST-MVT (Fig. 2D). None of the other synemin 
fusion proteins were precipitated by either VT or MVT. GST alone did not precipitate any of 
the FLAG-tagged synemin fusion proteins. Interactions of MBP-SNTless with GST-VT and 
GST-MVT were also tested by GST pull-down assays. MBP-SNTless was not precipitated by 
either GST-VT or GST-MVT (data not shown). These results further indicated that SNTIII is 
the region that interacts directly with vinculin or metavinculin. 
 
Binding of SNTIII to VT is regulated by the intramolecular head-tail association of 
vinculin 
Vinculin cycles between “open” and “closed” conformations, which is regulated by the 
intramolecular association between the head and tail domains [36, 37]. The vinculin head-tail 
association is known to block most of the ligand binding sites, such as those for talin [38] and 
α-actinin [39] in the head domain, and for F-actin [40] in the tail domain. To confirm the in 
vivo interaction of SNTIII with the VT, NIH/3T3 cells were transfected with EGFP-tagged 
SNTIII plasmids and subjected to immunoprecipitation with anti-GFP pAb. Because 
PtdIns(4,5)P2 has been reported to induce a conformational change in vinculin that results in 
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increased binding to its ligands [34, 41, 42], immunoprecipitation assays also were conducted 
in the presence or absence of exogenous PtdIns(4,5)P2. As shown in Fig. 3, in the presence of 
PtdIns(4,5)P2, vinculin was co-precipitated with EGFP-SNTIII by the anti-GFP pAb, 
demonstrating an interaction between vinculin and SNTIII. Without exogenous PtdIns(4,5)P2, 
vinculin was not detected in the samples of EGFP-SNTIII precipitation, indicating that the 
association between vinculin and SNTIII is promoted by PtdIns(4,5)P2. These data are 
consistent with a model in which ligand binding can be regulated by the intramolecular 
head-tail association of the vinculin molecules.  
 
The C-terminal 104 amino acid sequence of SNTIII contains the primary binding site 
for vinculin and metavinculin 
To further define the region within human α-synemin that mediates interaction with VT and 
MVT, SNTIII was divided into three consecutive sub-fragments named SNTIIIa, SNTIIIb, 
and SNTIIIc (Fig. 1A). This division of SNTIII was done according to the regions within its 
cDNA sequence where optimal primer design was possible. The three sub-fragments were all 
cloned as MBP-tagged fusion proteins. Full-length SNTIII was also generated as an 
MBP-tagged fusion protein and was used in parallel as a positive control in subsequent 
experiments (Fig. 4A). Specific interaction of each sub-fragment with VT and MVT was 
analyzed by blot overlay assays. As shown in Fig. 4B, MBP-tagged full-length SNTIII 
demonstrated specific interactions with both VT and MVT as had the FLAG-tagged SNTIII. 
This result indicates the interactions are highly specific regardless of the nature of the 
attached recombinant tag. SNTIIIc, which is the C-terminal 104 amino acid sequence of 
SNTIII, showed similar binding activities as the full-length SNTIII with VT and MVT (Fig. 4, 
B and C). Relative weak binding of SNTIIIa, the N-terminal 93 amino acid sequence of 
SNTIII, to VT/MVT was observed (Fig. 4, B and C). No interaction of SNTIIIb, the central 
115 amino acid sequence within SNTIII, with VT or MVT was observed in the blot overlay 
assays. These results indicate that the primary binding site for vinculin and metavinculin in 
human α-synemin is located in the C-terminal 104 amino acid sequence within SNTIII. 
 
Interactions of VT and MVT with SNTIII/SNTIIIc are saturable and act in a 
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competitive manner 
To determine whether the interactions of SNTIII and SNTIIIc with VT or MVT are saturable 
and to provide quantitative assessments of the interactions, solid phase binding assays by 
ELISA were conducted as previously described [33]. Increasing concentrations of 
MBP-SNTIII or MBP-SNTIIIc were added to 96-well plates coated with equal picomoles of 
GST-VT or GST-MVT per well. Duplicate plates incubated with increasing concentrations of 
purified MBP alone served as controls. As shown in Fig. 5, interactions of SNTIII with VT 
(Fig. 5A, circles) and MVT (Fig. 5B, circles) are both dose dependent and saturable. 
Determination of the concentrations of MBP-SNTIII at the half-maximal A405 yielded Kd 
values of 25 ± 4 nM and 53 ± 7 nM for SNTIII binding to VT and MVT, respectively. 
Similarly, interactions of SNTIIIc with VT (Fig. 5A, triangles) and MVT (Fig. 5B, triangles) 
were also dose dependent and saturable, yielding Kd values of 55 ± 9 nM and 70 ± 11 nM. 
No specific interactions were observed between MBP alone and the VT or MVT (Fig. 5, A 
and B, squares). Experiments using 96-well plates coated with GST alone also did not show 
any specific interactions of SNTIII or of SNTIIIc with GST itself (data not shown). These 
results provide further evidence that interactions of SNTIII or SNTIIIc with VT and MVT are 
highly specific.  
We also determined whether VT and MVT compete with each other in binding to SNIIIc. 
Purified MBP-SNTIIIc at a previously determined saturation concentration (300 nM, Fig. 5B) 
along with increasing concentrations of GST-VT were added to 96-well plates coated with 
GST-MVT. With increase in concentration of VT, the amount of SNTIIIc bound with MVT 
decreased as reflected by the A405 (Fig. 5C). This result indicates that VT competes with 
MVT for binding to SNTIIIc. 
 
Synemin colocalizes with vinculin/metavinculin within costameres of human adult 
skeletal muscle cells 
To examine the relationship of synemin and vinculin/metavinculin within a cellular context 
such as mammalian muscle cells, subcellular locations of synemin and vinculin/metavinculin 
within human adult skeletal muscle cells were analyzed by immunohistochemistry using 
confocal microscopy. Expression of both α- and β-synemins in human skeletal muscles was 
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first confirmed by reverse-transcriptase PCR amplifying synemin cDNA fragments from a 
human skeletal muscle total RNA library. The primer pair of 
5’-GAAAAAGAAATTAAAATACCCCACGAA-3’ and 
5’-AAACCAATGCCCATCATTCTC-3’ was used in the PCR, which will amplify a ~1 kb 
cDNA fragment from β-synemin mRNA and a ~2 kb fragment from α-synemin mRNA. The 
result indicated that both α-synemin and β-synemin mRNAs are present within human 
skeletal muscle cells (Fig. 6A, left panel). The two amplified fragments were also confirmed 
as synemin cDNAs by automated sequencing. Anti-synemin 2856 pAb was then used for 
immunolabeling of synemin within the human skeletal muscle cells. This antibody was 
previously shown to specifically recognize both human α- and β-synemins expressed within 
mammalian cells [43] as well as porcine α- and β-synemins [11]. We also analyzed the 
specificity of this antibody for human synemin by Western blotting. The results showed that 
the anti-synemin 2856 recognizes two specific bands at about 180 kDa and 150 kDa within 
both human skeletal muscle and human uterine smooth muscle total protein lysates (Fig. 6A, 
right panel). These molecular weights correspond in size to human α-synemin (180 kDa) and 
β-synemin (150 kDa). The relative expression levels of these two synemin isoforms are in 
agreement with previous studies reporting that the smaller β-synemin is expressed in a 
relatively higher amount than that of the larger α-synemin isoform in human skeletal muscle 
tissues, and is expressed in an approximately equal amount with that of α-synemin in human 
smooth muscle tissues [19, 21, 44]. 
Double immunofluorescence staining of synemin, and either desmin, α-actinin, or vinculin, 
within human adult skeletal muscle cells was then performed using anti-synemin 2856, 
anti-desmin DEU-10, anti α-actinin BM7.5, and anti-vinculin hVIN-1. Anti-vinculin hVIN-1 
recognizes a specific epitope within the head domain of vinculin. Thus, this antibody also 
labels any metavinculin expressed within human skeletal muscles. In longitudinal sections, 
synemin colocalized with desmin in striated patterns at the myofibrillar Z-lines (Fig. 6, B-D). 
This result is in agreement with previous studies showing colocalization of synemin and 
desmin at the Z-lines within mammalian skeletal muscles [11, 19, 21], indicating the 
formation and presence of synemin/desmin heteropolymeric IFs.  
In both longitudinal and cross sections the labeling of vinculin was primarily restricted to 
 35
along the sarcolemma (Fig. 6, G and K). In cross sections, the labeling of synemin was not 
only within each muscle fiber, but also significantly colocalized with vinculin along the 
sarcolemma (Fig. 6, E-H, arrows). In longitudinal sections, striations of synemin labeling 
ended on the sarcolemma that was labeled with vinculin (Fig. 6, I-L), and colocalized with 
vinculin in dot-like structures consistent with the costameres present periodically along the 
sarcolemma (Fig. 6L, small window, arrows). These confocal microscopy results indicate 
association of synemin with vinculin and metavinculin within mammalian (human) skeletal 
muscle cells. 
We previously reported the interaction of avian synemin with α-actinin [20, 23]. Thus, 
localizations of human synemin and α-actinin within human skeletal muscle tissues were also 
examined. Synemin co-localized with α-actinin at the myofibrillar Z-lines as well as along 
the sarcolemma (Fig. 6, M-P, arrows), indicating co-localization of synemin with α-actinin 
within mammalian (human) skeletal muscle cells. 
 
SNTIII and SNTIIIc colocalize with vinculin at focal adhesion (FA) sites within A-10 
cells 
To further clarify whether SNTIII and SNTIIIc interact with vinculin and metavinculin 
within living cells, the subcellular localization of expressed SNTIII and SNTIIIc was 
examined by confocal microscopy. A-10 cells, a rat smooth muscle cell line, were transiently 
transfected with EGFP-SNTIII or EGFP-SNTIIIc plasmids and immunolabeled with 
anti-vinculin hVIN-1. Cells with moderate expression level of green fluorescent proteins 
were then examined. Transfection of the EGFP vector alone into A-10 cells served as a 
reference and showed classical non-specific localization throughout the cytoplasm (Fig. 7B). 
Localization of vinculin was restricted primarily to both the large focal adhesions (FAs) and 
the smaller focal complexes (Fig. 7, C, G and K). Both EGFP-SNTIII and EGFP-SNTIIIc 
clearly colocalized with vinculin within FAs (Fig. 7, H and L), further supporting our 
findings obtained in the in vitro protein-protein binding assays. In addition, the distribution of 
SNTIII within the FAs was clearly independent of vimentin IFs, as shown by confocal 
images of EGFP-SNTIII transfected cells immunolabeled with anti-vimentin V9 (Fig. 7, 
M-P). Previous results indicated that full-length human synemin associates with vimentin IFs 
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within transfected mammalian cells [19]. Thus, our results herein suggest that interaction of 
SNTIII with vinculin helps link the synemin/vimentin heteropolymeric IFs directly to the 
FAs.  
 
SNβT and SNTless did not localize to FAs 
To ascertain whether only SNTIII and SNTIIIc co-localize with vinculin in FAs, subcellular 
localizations of expressed protein domains of β-synemin that do not contain the SNTIII 
region were examined in A-10 cells using confocal microscopy. Human β-synemin was 
divided into two regions named SNβT and SNTless. SNβT is the full-length C-terminal tail 
domain of β-synemin, which does not contain the N-terminal head and rod domains. SNTless 
is the N-terminal head and rod domains of β-synemin. Both of the two regions were cloned 
into EGFP vectors and subsequently transfected into A-10 cells. Transient expression of 
EGFP-SNβT within the A-10 cells resulted in a diffuse cytoplasmic distribution without any 
specific FA-like structures (Fig. 8, A-D). Transfection of EGFP-SNTless into the A-10 cells 
resulted in numerous perinuclear aggregates within the cytoplasm that did not colocalize with 
vinculin (Fig. 8, E-G). The latter result agrees with the studies of “tail-less” vimentin [45], 
desmin [46], and glial fibrillary acidic protein (GFAP) [47], in which all three showed 
formation of cytoplasmic aggregates within the transfected cells. Clearly, neither SNβT nor 
SNTless colocalized with vinculin within FA sites (Fig. 8, D and G). The latter set of results 
demonstrated that only regions from α-synemin (SNTIII and SNTIIIc) specifically 
co-localized with vinculin in FAs. 
 
Expression of SNTIII within A-10 cells did not disrupt normal cellular architectures 
To examine whether exogenous expression of SNTIII may cause mislocalization of 
endogenous proteins, the overall appearances of FAs, actin stress fibers, and IFs within 
EGFP-SNTIII transfected A-10 cells were analyzed using epifluorescence microscopy. As 
shown in Fig. 9, the organizations of the FAs (Fig. 9B), actin stress fibers (Fig. 9D), and 
vimentin IFs (Fig. 9F) within EGFP-SNTIII expressing cells (Fig. 9, arrows) did not display 
significant changes in comparison with surrounding cells without EGFP-SNTIII expression. 
These results indicate that expression of SNTIII did not disrupt the normal cellular 
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architectures within the transfected cells. Therefore, co-localization of SNTIII with vinculin 
at FA sites as shown in Fig.7 is not a result of non-specific distribution of SNTIII within the 
cells. 
 
DISCUSSION 
In the present study we have defined the interactions of human α- and β-synemins with 
vinculin and metavinculin. Recombinant protein regions that include the entire amino acid 
sequence of human synemin were generated to map the vinculin/metavinculin binding site(s). 
Blot overlay assays showed that SNTIII, the 312 amino acid insert present only in α-synemin, 
interacts with both VT and MVT (Fig. 2B). These interactions are highly specific as indicated 
by the absence of interactions of SNTIII with both BSA and GST, which served as negative 
controls (Fig. 2B and Fig. 4B). Furthermore, both FLAG-tagged and MBP-tagged SNTIII 
showed specific interactions with VT and MVT (Fig. 2B and Fig. 4B), demonstrating that the 
interactions are not dependent on the nature of the attached fusion tag. In vitro GST 
pull-down assays provided additional information regarding the interactions of different 
regions of human synemin with VT and MVT, also demonstrating specifically that only 
SNTIII present in α-synemin interacts with both VT and MVT (Fig. 2, C and D). 
The primary binding site for VT/MVT within SNTIII was further mapped to its C-terminal 
104 amino acid sequence (SNTIIIc) (Fig. 4B). As shown in the solid phase binding assays 
(Fig. 5, A and B), SNTIIIc binds to VT and MVT with higher dissociation constants than 
those obtained with SNTIII. This indicates that the full-length SNTIII has higher affinities for 
VT and MVT than the truncated form (SNTIIIc). Also, SNTIIIa, albeit much weaker than 
that of SNTIIIc, has affinity to VT and MVT. Thus, the full-length SNTIII may exhibit 
optimal interactions with VT and MVT in vitro and/or in vivo.  
Interactions of VT with SNTIII and with SNTIIIc also showed lower dissociation constants 
than those of MVT, indicating higher affinity of VT for α-synemin. The latter difference in 
the binding affinities could result from the presence of the additional 68 amino acid insert 
within the MVT, which may interfere with its binding to SNTIIIc. VT and MVT also 
compete with each other for binding to SNTIIIc (Fig. 5C), indicating that they bind to the 
same site on α-synemin. 
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We have also examined for the first time the subcellular localization of different regions of 
human synemin within mammalian muscle cells by confocal microscopy. The subcellular 
localization pattern of proteins, or protein domains, often reflects their actual cellular 
functions. We demonstrated by transfection studies that SNTIII and SNTIIIc colocalized with 
vinculin at FA sites within mammalian smooth muscle cells (Fig. 7, E-L). This provides 
additional evidence for the specific in vivo interactions of SNTIII and SNTIIIc with vinculin 
and metavinculin. SNβT and SNTless, which together cover the entire amino acid sequence 
of β-synemin, showed subcellular localizations distinct from those of SNTIII and SNTIIIc, 
by not labeling vinculin-containing FA sites (Fig. 8). These results further demonstrate that it 
is SNTIII, which is absent in β-synemin, that specifically interacts with vinculin and 
metavinculin, and thereby is targeted to FAs within mammalian muscle cells. The 
localizations of SNTIII and SNTIIIc within FAs were also independent of the vimentin IFs 
(Fig. 7, M-P). It has been reported that both full-length human α-synemin or β-synemin 
colocalized with vimentin when transiently expressed within mammalian cells [19]. These 
different localization patterns between SNTIII and full-length human synemin indicate that 
SNTIII is the region within human α-synemin that helps link synemin/vimentin 
heteropolymeric IFs to the FA sites. Confocal microscopy studies of subcellular localization 
of synemin and vinculin/metavinculin within human adult skeletal muscle cells also reveal 
that synemin colocalizes with vinculin within the costameres (Fig. 6L), which are considered 
specialized focal adhesions located along and subjacent to the sarcolemma [26]. Thus, 
α-synemin may directly link the synemin/desmin heteropolymeric IFs to the vinculin rich 
costameric structures within the mammalian (human) skeletal muscle cells. 
We have provided evidence that interaction of α-synemin with VT may also be regulated 
by the molecular conformation of vinculin within a cellular context. The 
immunoprecipitation studies showed that vinculin was precipitated by SNTIII in the presence 
of exogenous PtdIns(4,5)P2 (Fig. 3). This may reflect that the soluble pool of vinculin in the 
cell lysates was in the “closed” form, which would block the binding site of SNTIII within 
the vinculin tail domain. It is known that PtdIns(4,5)P2 interferes with the “closed” form of 
vinculin [41, 42], which would thereby allow binding of SNTIII to the VT. It was recently 
shown that vinculin is in its activated (“open”) form when recruited in FAs [48]. Thus, 
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localization of SNTIII within FAs may result from the direct interaction with the VT of 
activated vinculin. Recent studies have reported close associations of FAs and IFs within 
mammalian cells [49-51]. It has also recently been shown that FAs are critical sites for the 
nascent assembly of vimentin [49] and keratin [50] IFs. However, direct interactions of IFs 
with specific components of FAs were not identified in those studies. Our results provide the 
first in vitro/in vivo evidence of direct interaction of IF proteins with components of FAs. 
Whether interaction of α-synemin with vinculin is able to direct the nascent formation of 
vimentin IFs at FAs remains to be explored. 
Overall, the results of this study show that α-synemin, but not β-synemin, interacts directly 
with both vinculin and metavinculin. These findings indicate that the human α- and 
β-synemin isoforms have different cellular functions. The sequence of α-synemin is identical 
to β-synemin with the exception of the additional 312 amino acid insert in its tail domain. 
Our results indicate that this additional insert confers extra functions for α-synemin. 
Interaction of α-synemin with vinculin and metavinculin may directly anchor the 
heteropolymeric IFs to adhesion-type junctions, such as the costameric regions within 
striated muscle cells. The latter interactions within costameres would strengthen the linkage 
of the synemin/desmin heteropolymeric IFs to the cell membrane, and thereby help maintain 
the structural integrity and functional stability of the muscle cell cytoskeleton during muscle 
contraction. 
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Figure 1. Schematic diagram of each protein and construct used in the in vitro binding studies. 
A, Schematic diagram of human synemin and the synemin constructs. Human synemin is composed 
of a short, ten-amino acid head domain (H), a conserved central 310 amino acid rod domain (rod), and 
a long C-terminal tail domain (Tail). Human α- and β-synemin sequences are identical except that 
α-synemin contains an additional 312 amino acid insert (SNTIII, ~33kDa) located near the end of the 
C-terminal tail. Human α- and β-synemins were divided as illustrated. The predicted molecular 
weight (without tags), and the relative position of each fragment in the amino acid sequence, are 
shown. Fragments spanning the human β-synemin tail domain (SNTIa, SNTIb, and SNβTII) were 
cloned into pFLAG-ATS vector as FLAG-tagged fusion proteins. SNTless and the three 
sub-fragments of SNTIII (SNTIIIa, SNTIIIb, and SNTIIIc) were cloned into pMALC2X vector as 
MBP fusion proteins. SNTIII was constructed as both a FLAG-tagged fusion protein and an 
MBP-tagged fusion protein. B, Schematic diagram of vinculin/metavinculin and the tail constructs. 
Vinculin and metavinculin are composed of a globular head domain, a proline rich linker, and an 
elongated tail domain. The metavinculin contains additional 68 amino acids (shaded oval) within the 
tail domain. Vinculin and metavinculin tail domains were cloned as GST fusion proteins.  
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Figure 2. SNTIII interacts with both vinculin and metavinculin tail domains in vitro. A, 
SDS-PAGE of purified synemin fusion proteins. B, Blot overlays. One hundred picomoles of purified 
GST-VT, GST-MVT, BSA, and GST alone were electrophoresed and transferred to nitrocellulose 
membranes. After blocking, membranes were overlaid with or without 10 μg/ml purified synemin 
fusion proteins in 1% milk-phosphate buffered saline, pH 7.4. Bound synemin fusion proteins were 
detected with anti-FLAG or anti-MBP pAb by chemiluminescnece. Only SNTIII binds to both VT 
and MVT. C. GST-VT or GST alone was immobilized on glutathione agarose and incubated with each 
purified FLAG-tagged synemin tail fragment as described in the “Experimental Procedures” section. 
The resulting eluates were each divided into equal volumes and subjected to Western blot analysis 
with anti-FLAG pAb and anti-GST mAb, respectively. D. The same experimental design was 
followed as described in C, with the substitution of GST-MVT for GST-VT. SNTIII is specifically 
precipitated by GST-VT and GST-MVT. 
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Figure 3. Immunoprecipitation of vinculin with over-expressed SNTIII in NIH/3T3 cells. 
NIH/3T3 cells were transfected with EGFP-SNTIII plasmids or EGFP vector alone. Twenty four 
hours post transfection, the cells were lysed, and the resulting cell lysates were incubated with 
anti-GFP pAb immobilized on protein A agarose, in the presence or absence of 100 μM PtdIns(4,5)P2. 
Each resulting immunoprecipitate was divided into equal volumes and subjected to Western blot 
analysis with anti-vinculin mAb hVIN-1 or HRP-conjugated anti-GFP pAb, respectively. Mock, 
which served as a negative control, denotes the incubation of mock transfected cell lysates with 
anti-GFP immobilized on protein A agarose. Lys denotes the load of non-transfected NIH/3T3 cell 
lysates. Vinculin was immunoprecipitated by anti-GFP pAb along with the EGFP-SNTIII in the 
presence of 100 μM PtdIns(4,5)P2. 
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Figure 4. The C-terminal 104 amino acid sequence of SNTIII is the primary binding site for 
both vinculin and metavinculin.  A, SDS-PAGE of purified MBP-SNTIII and the 3 MBP-tagged 
sub-fragments. B, Blot overlays. As in Fig. 2B, one hundred picomoles of purified GST-VT, 
GST-MVT, BSA, and GST alone were subjected to SDS-PAGE and transferred to nitrocellulose 
membranes. The membranes were then overlaid with or without 10 μg/ml purified MBP-tagged 
SNTIII sub-fragments. Bound proteins were detected with anti-MBP pAb. Overlay of MBP-tagged 
full-length SNTIII served as a positive control. C, Densitometry analysis of three independent 
replicates of blot overlay assays. Signal intensity of background on each blot was set as zero. SNTIIIc 
showed similar affinity with VT and MVT as the full-length SNTIII did. 
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Figure 5. Interactions of VT and MVT with SNTIII or with SNTIIIc are both saturable and act 
in a competitive manner. A and B, 96-well plates were coated with 100 nM purified GST-VT (A) or 
GST-MVT (B) and incubated with increasing concentrations of MBP-SNTIII (circles), MBP-SNTIIIc 
(triangles), or MBP alone (squares) for 1 hour at 25°C. After extensive washing, bound MBP fusion 
proteins were detected with HRP-conjugated anti-MBP mAb and the HRP substrate ABTS by 
measurement of A405. Background A405 values of wells incubated with buffer only were subtracted. 
The resulting A405 values were plotted versus the concentration of incubated MBP fusion proteins. 
The values represent the mean ± s.d. from three independent experiments (the data were fitted to a 
moving average trendline with a period of 2). Interactions of VT and MVT with SNTIII, or with 
SNTIIIc, were both saturable. C, increasing concentrations of GST-VT, along with 300 nM purified 
MBP-SNTIIIc, were added to a 96-well plate coated with GST-MVT for 1 hour at 25°C. Bound 
SNTIIIc was then determined as described in A and B. Values represent the mean ± s.d. from three 
independent experiments. The values were plotted versus the concentration of GST-VT, and fitted to a 
linear regression trendline. The VT competes with the MVT for the interaction with SNTIIIc.   
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Figure 6. Confocal microscopy studies indicate synemin colocalizes with vinculin within human 
adult skeletal muscle cells. A, Left panel, reverse-transcriptase PCR amplifying a ~1 kb cDNA 
fragment from β-synemin mRNA and a ~2 kb cDNA fragment from α-synemin mRNA that present in 
a human skeletal muscle total RNA library. Right panel, Western blotting of human adult skeletal 
muscle (SK) and uterine smooth muscle (UT) total protein lysates with anti-synemin 2856 pAb. Fifty 
μg of each total protein lysate was separated by SDS-PAGE and subjected to Western blotting using 
anti-synemin 2856. B-D, Confocal microscopy analysis of the localization of synemin and desmin 
within longitudinal sections of human skeletal muscle. Synemin was labeled green with anti-synemin 
2856 pAb and secondary Alexa Fluoro 488 goat anti-rabbit IgG. Desmin was labeled red with 
anti-desmin DEU-10 mAb, followed by staining with secondary Alexa Fluoro 594 goat anti-mouse 
IgG. Synemin colocalized with desmin at the myofibrillar Z-lines (D). E-L, Confocal microscopy 
analysis of synemin and vinculin within human skeletal muscle. Synemin was labeled green with 
anti-synemin 2856. Vinculin was labeled red with anti-vinculin hVIN-1 mAb. F, G, and H represent 
the boxed area in E. J, K, and L represent the boxed area in I. In cross sections (E-H), synemin 
colocalized with vinculin along the sarcolemma (H, arrows). In longitudinal sections (I-L), synemin 
colocalized with vinculin within the costameres (L, small window, arrows). M-P, Confocal 
microscopy analysis of synemin and α-actinin within human skeletal muscle. Synemin was labeled 
green with anti-synemin 2856. α-Actinin was labeled red with anti-α-actinin mAb BM7.5. N, O, and 
P represent the boxed area in M. Synemin colocalized with α-actinin at the myofibrillar Z-lines as 
well as along the sarcolemma (P, arrows). (Bars, 25 μm) 
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Figure 7. SNTIII and SNTIIIc specifically localize within FAs in A-10 cells. A-L, A-10 cells were 
transfected with EGFP, EGFP-SNTIII, or EGFP-SNTIIIc plasmids. Vinculin was then labeled red 24 
hours post transfection with anti-vinculin hVIN-1 plus secondary Alexa fluoro 594 goat anti-mouse 
IgG. The last three pictures in each row represent enlarged views of the boxed area in the first picture. 
SNTIII and SNTIIIc both co-localized with vinculin within FAs (H and L). M-P, A-10 cells were 
transfected with EGFP-SNTIII plasmids. Cells were then immunostained 24 hours post transfection 
with anti-vimentin V9 and secondary Alexa fluoro 594 goat anti-mouse IgG. N-P represents the boxed 
area in M. SNTIII localized within FA like structures at the cell periphery where vimentin was absent. 
(Bars, 25 μm) 
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Figure 8. SNβT and SNTless, which together cover the full-length amino acid sequence of 
β-synemin, do not colocalize with vinculin. A-D, Confocal microscopy of subcellular localization of 
SNβT within A-10 cells. A-10 cells were transfected with EGFP-SNβT plasmids and then 
immunostained with anti-vinculin hVIN-1. B-D represents enlarged views of the boxed area in A. E-G, 
Subcellular localization of EGFP-SNTless within A-10 cells. A-10 cells were transfected with 
EGFP-SNTless plasmids. Vinculin was then labeled red with anti-vinculin hVIN-1. Neither SNβT nor 
SNTless colocalized with vinculin within FAs. (Bars, 25 μm) 
 
 54
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Expression of SNTIII did not result in significant changes in the cellular organization 
of FAs, actin stress fibers, and IFs. A-10 cells were transfected with EGFP-SNTIII plasmids 
followed by immunostaining of vinculin, F-actin, and vimentin to label the FAs (B), actin stress fibers 
(D), and IFs (F), respectively. B, D, and F represent the same microscope observation field as A, C, 
and E, respectively. Arrows indicate the identical cell(s) in the same microscope observation field. In 
comparison to the surrounding cells without EGFP-SNTIII expression, cells that express 
EGFP-SNTIII did not display any significant difference in the appearances of the FAs, actin stress 
fibers, and IFs. (Bars, 15 μm) 
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Footnotes 
Abbreviations used: IF(s), intermediate filament(s); FA(s), focal adhesion(s); VT, vinculin 
tail; MBP, maltose binding protein; GST, glutathione S-transferase; BSA, bovine serum 
albumin; pAb, polyclonal antibody; mAb, monoclonal antibody; SNT, synemin tail; SNβT, 
β-synemin tail. 
 
Abstract 
The type VI intermediate filament (IF) protein synemin is a unique member of the IF protein 
superfamily. Synemin associates with the major type III IF protein desmin forming 
heteropolymeric intermediate filaments (IFs) within developed mammalian striated muscle 
cells. These IFs encircle and link all adjacent myofibrils together at their Z-lines, as well as 
linking the Z-lines of the peripheral layer of cellular myofibrils to the costameres located 
periodically along and subjacent to the sarcolemma. Costameres are multi-protein assemblies 
enriched in the cytoskeletal proteins vinculin, α-actinin, and talin. We report herein a direct 
interaction of human α-synemin with the cytoskeletal protein talin by protein-protein 
interaction assays. The 312 amino acid insert (SNTIII) present only within α-synemin binds 
to the rod domain of talin in vitro and co-localizes with talin at focal adhesion sites within 
mammalian muscle cells. Confocal microscopy studies showed that synemin co-localizes 
with talin within the costameres of human skeletal muscle cells. Analysis of the primary 
sequences of human α- and β-synemins revealed that SNTIII is composed of seven tandem 
repeats, each containing a specific Ser/Thr-X-Arg-His/Gln (S/T-X-R-H/Q) motif. Our results 
suggest human α-synemin plays an essential role in linking the heteropolymeric IFs to 
adherens-type junctions, such as the costameres within mammalian striated muscle cells, via 
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its interaction with talin, thereby helping provide mechanical integration for the muscle cell 
cytoskeleton.  
 
KEYWORDS, intermediate filament, synemin, talin, cytoskeleton, costameres, muscle cell 
 
Introduction 
The cytoskeleton of mammalian cells is comprised primarily of three types of filamentous 
networks, namely microtubules, microfilaments, and intermediate filaments (IFs) [1, 2]. The 
long ~10 nm diameter IFs are believed to play essential roles in maintaining the 
morphological integrity and functional stability of living cells [3-5]. The IFs are 
heterogeneous in nature, and composed of cell-type specific IF proteins. Approximately 65 IF 
proteins have been identified in humans [6]. These have been classified into ~six major types 
based upon the degree of nucleotide sequence homology and the genomic structures of the IF 
genes [7]. 
Synemin is a very large, unique IF protein that is present primarily in the three types 
(skeletal, cardiac, and smooth) of muscle tissues [8]. The single human synemin gene 
encodes two large splice variants, α-synemin and β-synemin, with the larger α-synemin 
containing an additional 312 amino acid insert near the end of the long C-terminal tail 
domain [9]. Assembly of either α-synemin or β-synemin into IFs requires the presence of the 
major type III IF proteins desmin and/or vimentin, which then form heteropolymeric IFs 
within mammalian cells [8-10]. Synemin has previously been shown to interact with non-IF 
proteins including α-actinin, vinculin, α-dystrobrevin, and dystrophin, which are cytoskeletal 
proteins present in adherens-type junctions including costameres, neuromuscular junctions, 
and myotendinous junctions within striated muscle cells [11-14]. Thus, synemin appears able 
to link the heteropolymeric IFs to the adherens-type junctions within striated muscle cells. 
Like synemin, the cytoskeletal protein talin is also localized in costameres, neuromuscular 
junctions, and myotendinous junctions within mammalian muscle cells [15-17]. Talin harbors 
multiple binding sites for different cytoskeletal proteins and signaling molecules, and appears 
to act as an adaptor protein within cell-extracellular matrix contacts [18, 19]. Talin also plays 
essential roles in relaying “outside-in” and “inside-out” signals across the plasma membrane, 
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and is critical for integrin activation [20, 21].  
  In the present study we provide evidence that a specific region located within the long rod 
domain of talin interacts with the 312 amino acid insert (SNTIII) present only within human 
α-synemin. Furthermore, analysis of the primary sequence of SNTIII reveals that it is 
composed of seven ~39 amino acid long tandem repeats containing specific 
Ser/Thr-X-Arg-His/Gln (S/T-X-R-H/Q) motifs, where X represents any of the five amino 
acid residues V, G, I, F, L. Results of our studies support a model in which α-synemin 
interacts directly with talin, and thereby helps to link the synemin/desmin heteropolymeric 
IFs to adherens-type junctions within developed mammalian (human) muscle cells.  
 
Materials and methods 
Generation of cDNA constructs  
The human β-synemin cDNA fragment encoding amino acid residues 322-1251 (SNβT) and 
the human α-synemin cDNA fragment encoding amino acid residues 1153-1464 (SNTIII) 
were PCR amplified and subcloned into pFLAG-ATS expression vectors (Sigma, St. Louis, 
MO) at 5’ Hind III and 3’ Bgl II sites. Synemin cDNA fragment encoding amino acid 
residues 1-329 (SNTless) was PCR amplified and subcloned into pMAL-C2X maltose 
binding protein (MBP) expression vector (New England Biolabs, Ipswich, MA) at 5’ EcoR I 
and 3’ Sal I sites. SNTIII was also cloned into pMAL-C2X vector and into enhanced green 
fluorescent protein (EGFP) expression vector (Clontech, Mountain View, CA) at 5’ Hind III 
and 3’ BamH I sites. Human talin1 cDNAs encoding the head domain (amino acid residues 
1-433, Head), and regions of the rod domain (amino acid residues 423-1326, R1; 1327-1948, 
R2; and 1942-2541, R3) were amplified by reverse transcriptase-PCR from the Human 
Skeletal Muscle Total RNA Library (BD Biosciences, San Jose, CA) and subcloned into 
pGEX-4T2 glutathione S-transferase (GST) expression vector (GE Healthcare, Pittsburgh, 
PA) at 5’ Sal I and 3’ Not I sites. The cDNA of the R2 region (amino acid residues 1327-1948) 
of human talin1 was also cloned into DsRed red fluorescent protein expression vector 
(Clontech) at 5’ Sal I and 3’ BamH I sites. Accuracy of each construct was confirmed by 
automated sequencing in the DNA Sequencing and Synthesis Facility at Iowa State 
University (Ames, IA).  
 58
Expression and purification of recombinant proteins  
Recombinant fusion proteins were expressed in E.coli BL21-Codon Plus (DE3) bacterial 
cells (Stratagene, La Jolla, CA). FLAG-tagged synemin fusion proteins were affinity purified 
using Anti-FLAG M2-Agarose Affinity Gel (Sigma). GST-tagged talin1 fusion proteins were 
batch purified using Glutathione Agarose (Sigma). MBP-tagged synemin fusion proteins 
were batch purified using Amylose Resin (New England Biolabs). The concentration of each 
purified fusion protein was determined using Bio-Rad protein assays.  
Cell culture 
A-10 cells, a rat vascular smooth muscle cell line, were purchased from the American Type 
Culture Collection (Manassas, VA). Human uterine smooth muscle cells (UTSMC) were 
obtained from Lonza (Allendale, NJ). A-10 cells were maintained in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37° C (95% 
air, 5% CO2). Human UTSMC cells were maintained with Smooth Muscle Medium-2 
Bulletkit (Lonza) at 37° C (95% air, 5% CO2). 
Co-immunoprecipitation 
Co-immunoprecipitations were performed using the ProFound Mammalian 
Co-Immunoprecipitation Kit (Pierce, Rockford, IL) following the manufacturer’s instructions. 
Briefly, UTSMC cells were lysed with MPER Mammalian Protein Extraction Reagent 
(Pierce) and incubated with anti-talin 8d4 monoclonal antibody (mAb) covalently coupled to 
the Aminolink Plus Coupling Resin (Pierce). The Control Resin (Pierce) incubated with the 
same volume of UTSMC lysates was used in parallel as a negative control. The resins were 
then washed extensively with PBST (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 
mM KH2PO4, 0.1% Tween-20, pH 7.4) and then eluted with the ImmunoPure IgG Elution 
Buffer (Pierce). The eluates were then subjected to SDS-PAGE and analyzed by Western 
blotting using anti-synemin 2856 polyclonal antibody (pAb) [22] and anti-talin 8d4 mAb 
(Sigma).  
Blot overlay and dot blot overlay assays 
Blot overlay assays were conducted as previously described [22]. For the dot blot overlay 
assays, an equal molar amount of GST-talin R2, GST-VT, and GST alone were spotted onto a 
nitrocellulose membrane, with GST-VT and GST alone serving as a positive and a negative 
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control, respectively. The resulting membrane was blocked with PBST containing 5% (w/v) 
non-fat milk powder, and then overlaid with 10 μg/ml purified MBP-SNTIII or MBP alone in 
PBST containing 1% (w/v) milk. Bound proteins were detected with anti-MBP serum (New 
England Biolabs) by chemiluminescence.  
GST pull-down assays  
Two μg of GST-talin1-R2, or GST alone, were immobilized on glutathione agarose and then 
incubated with the same amount of purified FLAG-SNTIII in PBS for 12 h at 4° C. The 
beads were then precipitated, washed extensively with PBS containing 0.5% Tween-20, and 
eluted with 2X SDS sample buffer. The resulting eluates were subjected to SDS-PAGE and 
analyzed by Western blotting with anti-FLAG pAb (Sigma) and anti-GST mAb (Santa Cruz 
Biotechnology, Santa Cruz, CA). 
Solid phase binding assays by ELISA 
Duplicate 96-well microtiter plates (Nunc, Rochester, NY) were coated with either 100 nM 
purified GST-talin R2 or GST-VT for 16 h at 4° C. The wells were then blocked with PBS 
containing 1% (w/v) milk for 3 h at 37° C, and incubated with increasing concentrations of 
purified FLAG-tagged SNTIII fusion protein for 1 h at 25° C. Wells were extensively washed 
with PBST and then incubated with HRP-conjugated anti-FLAG M2 mAb (Sigma) for an 
additional 1 h at 25° C. After extensive washing with PBST, protein interactions were 
detected with the HRP substrate 2,2'-azino-bis-[3-ethylbenzthiazoline-6-sulfonic acid] 
(ABTS) (Southern Biotechnology, Birmingham, Alabama) by measuring absorbance at 405 
nm (A405). Data were then plotted using Microsoft Excel. 
Transfection studies, immunofluorescence, and confocal microscopy 
For transfection studies, A-10 cells were seeded on rat tail collagen I (BD 
Biosciences)-coated glass coverslips to reach 50% confluence. Cells were then transfected 
with EGFP-SNTIII or co-transfected with EFGP-SNTIII and DsRed-talin R2 plasmids using 
JetPEI Transfection Reagent (Polyplus Transfection, San Marcos, CA), followed by 
incubation at 37° C for 24 h. For immunofluorescence, the transfected cells were fixed with 
2% formaldehyde in PBS, permeabilized with 0.2% Triton-X 100 in PBS, and blocked with 
5% bovine serum albumin (BSA) in PBS. The cells were then incubated with appropriate 
primary antibodies and Alexafluor secondary antibodies (Invitrogen, Carlsbad, CA). After 
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extensive washing with PBS, the slides were mounted with Vectashield Mounting Medium 
(Vector Laboratories, Burlingame, CA). Immunofluorescence using human adult skeletal 
muscle tissue sections (Biochain, Hayward, CA) was conducted following the procedures 
described for the immunofluorescence of the transfected cells without the fixation step. 
Confocal microscopy was conducted using a LEICA TCS NT Confocal Microscopy System 
in the Confocal Microscopy Facility at Iowa State University. 
Secondary protein structure prediction and repeat sequence analysis 
For prediction of secondary protein structure and analysis of repeat sequences, the reference 
sequences of human α-synemin (NCBI accession no. NP_663780) and β-synemin (NCBI 
accession no. NP_056101) from the protein database of the National Center for 
Biotechnology Information (NCBI) were used. To predict the secondary structure of SNTIII, 
the 312 amino acid sequence corresponding to the unique α-synemin insert, was submitted to 
the PredictProtein Server (http://www.predictprotein.org) [23]. For detection of repeat 
sequences, the primary sequence of human α-synemin was submitted to the Rapid Automatic 
Detection and Alignment of Repeats (RADAR) [24] at the European Bioinformatics Institute 
(EBI). Similarly, mouse H-synemin (NCBI accession no. NP_964001) and chicken synemin 
(NCBI accession no. NP_990140) sequences were also submitted to RADAR for repeat 
sequence analysis. Data of the RADAR alignments and the secondary structure predictions 
were submitted to ESPript 2.2 [25, 26] to generate postscript image files. 
 
Results 
SNTIII interacts directly with the talin rod domain 
To examine the putative interaction of synemin with talin in cells, co-immunoprecipitation 
experiments using cultured human uterine smooth muscle cell (UTSMC) lysates were 
performed. The UTSMC cells were selected in the present study because it was previously 
shown that smooth muscle tissues express a relatively high level and approximately equal 
amounts of both α- and β-synemins [9, 10]. Using the anti-talin mAb (clone 8d4) covalently 
coupled to the Aminolink resin, both human α- and β-synemins immunoprecipitated along 
with talin from the UTSMC cell lysates (Fig. 2A), indicating that synemin and talin are 
closely associated within the same immunocomplex.  
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To examine direct interaction between human synemin and talin, as well as to map the 
respective binding site(s) within the two molecules, interactions between regions of human 
synemin isoforms and regions of human talin were investigated. Human α- and β-synemins 
were divided into specific regions (shown in Fig. 1A), which include the full length primary 
sequences of the two molecules. SNTless and SNβT are regions shared by both α- and 
β-synemins. SNTIII represents the additional 312 amino acid insert that is present only in the 
larger α-synemin. Each region was expressed as a FLAG-tagged recombinant protein except 
SNTless that was expressed as an MBP-tagged fusion protein to increase its solubility during 
purification. Four overlapping regions, which span the full length amino acid sequence of 
talin, were generated and expressed as GST-tagged fusion proteins as diagrammed in Fig. 1B.  
  Blot overlay assays were conducted to examine the specific interactions between the 
synemin and talin regions. Blots containing GST-tagged talin fusion proteins, as well as 
GST-tagged vinculin tail (VT) and GST alone (Fig. 2B, top panel), were overlaid with each 
of the purified synemin recombinant regions, with GST-VT and GST alone serving as 
positive and negative controls, respectively. The bound synemin fusion proteins were then 
detected with anti-FLAG pAb or anti-MBP serum. As shown in Fig. 2B, SNTIII interacted 
specifically with the talin R2, as well as with the positive control VT [27], whereas SNTless 
and SNβT did not bind. These results indicate that the amino acid sequence 1327-1948 (R2) 
within the talin rod domain interacts with SNTIII.  
  Interaction of talin R2 with SNTIII was further confirmed by GST pull-down assays (Fig. 
2C) and by dot blot overlay assays (Fig. 2D). In the GST pull-down assays, purified 
FLAG-tagged SNTIII was precipitated by GST-talin R2 immobilized on glutathione agarose 
beads. The negative controls of GST alone and of beads alone did not result in precipitation 
of any FLAG-SNTIII (Fig. 2B). In dot blot overlay assays, purified GST-talin R2, along with 
the positive control GST-VT and the negative control GST alone, were spotted on a 
nitrocellulose membrane. The resulting membrane was then overlaid with purified 
MBP-tagged SNTIII or with MBP alone. As shown in Fig. 2D, SNTIII bound to talin R2 and 
the positive control VT, but not to the negative control of GST alone. In toto, these 
protein-protein binding assays demonstrated that SNTIII, the 312 amino acid insert within 
α-synemin, interacts specifically with talin R2. In addition, the specific interaction of SNTIII 
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with talin R2 is independent of the nature of the two attached fusion tags.  
 
Talin R2 competes with VT in binding to SNTIII 
To provide quantitative assessments of the interaction of SNTIII with talin R2, solid phase 
binding assays by ELISA were conducted. Equal molar concentrations of purified GST-talin 
R2, the positive control of GST-VT, and the negative control of GST alone were absorbed 
onto 96-well plates, and these were then incubated with increasing concentrations of purified 
FLAG-tagged SNTIII. Protein interactions were then measured as described in the “Material 
and Methods” section. The interaction of talin R2 with SNTIII was dose-dependent and 
saturable as was that of VT with SNTIII, which served as the positive control (Fig. 3A). The 
negative control of GST alone did not show any significant interaction with SNTIII. 
Determination of the concentration of FLAG-SNTIII at half-maximal A405 yielded a Kd value 
of 52 ± 11 nM for the talin R2 and SNTIII interaction. The Kd value for the VT and SNTIII 
interaction was 30 ± 8 nM, which is close to the value obtained in our previous study (25 ± 4 
nM) [27]. Our present results indicate that talin R2 binds to, and has similar affinity for, 
SNTIII in vitro as does the VT. 
To determine whether talin R2 and VT can bind simultaneously to SNTIII, competitive 
binding assays by ELISA were conducted. Increasing concentrations of GST-VT, along with 
400 nM purified FLAG-SNTIII (a saturated concentration obtained from Fig. 3A), were 
added to 96-well plates coated with purified GST-talin R2. As shown in Fig. 3B, VT 
competes with talin-R2 in binding to SNTIII. This result indicates that interaction of talin R2 
and VT with SNTIII are mutually exclusive. 
 
Synemin co-localizes with talin within the costameres in mammalian skeletal muscle 
cells 
To examine the relationship of synemin and talin within a cellular context, localization of 
synemin and of talin within human adult skeletal muscle tissues were analyzed by 
immunofluorescence and confocal microscopy. The anti-synemin 2856 pAb used in the study 
was previously verified as specifically recognizing both human and porcine α- and 
β-synemins [28, 29]. Double immunofluorescence labeling of synemin and desmin showed 
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that synemin colocalized with desmin at the myofibrillar Z-lines (Fig. 4, A-C). This result 
agrees with previous reports showing colocalization of synemin and desmin within 
mammalian skeletal muscle cells [9, 10, 13, 28, 29]. In cross sections, double 
immunofluorescence labeling of synemin and talin showed that synemin colocalized with 
talin along the sarcolemma (Fig. 4, D-F). In longitudinal sections, the striated synemin 
labeling ended at, and co-localized with, talin labeling within dot-like structures (Fig. 4, G-I, 
arrows). The latter structures are consistent with the location of the costameres present 
periodically along and immediately subjacent to the sarcolemma. These results of confocal 
microscopy indicate an intracellular association of synemin and talin within human striated 
muscle cells. 
 
SNTIII co-localizes with talin as well as talin R2 within transfected cells 
The ability of SNTIII and SNβT to localize to specific cellular structures was examined by 
transfecting A-10 rat smooth muscle cells with the appropriate EGFP-tagged expression 
constructs. Cells with moderate levels of GFP expression were examined. EGFP alone 
showed a classical non-specific distribution across the cytoplasm (data not shown). 
EGFP-tagged SNTIII displayed specific co-localization with talin within the focal adhesion 
(FA) sites (Fig. 5, A-D), while EGFP-tagged SNβT did not (Fig. 5, E-H). This result is 
consistent with our results obtained from the in vitro protein-protein interaction assays, which 
showed that it was SNTIII, but not SNβT, that interacted specifically with the talin rod 
domain. 
To examine whether SNTIII and talin R2 associate within living cells, EGFP-SNTIII and 
DsRed-talin R2 plasmids were co-transfected into A-10 cells. DsRed-tagged talin R2 
exhibited a typical subcellular localization within the FAs, which is in agreement with results 
from previous studies [30, 31]. EGFP-SNTIII co-localized with DsRed-talin R2 at FA sites 
within the transfected A-10 cells (Fig. 5, I-L). The results of these cellular transfection 
studies demonstrated a close intracellular association of SNTIII with talin R2 within living 
cells. 
 
Primary sequence analysis reveals that SNTIII is composed of seven tandem repeats.  
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That SNTIII interacts specifically with both the vinculin tail domain and talin rod domain 
could be reflected by its unique primary amino acid sequence, as well as its specific 
secondary structure. We therefore analyzed the amino acid sequence and predicted the 
secondary structure of SNTIII by using selected bioinformatics tools. In the search against 
the NCBI protein databases using BLASTp, the primary sequence of SNTIII (amino acid 
residues 1153-1464) was not homologous to any of the individual protein sequences in the 
current protein database. Also, SNTIII does not contain any defined, conserved 
domains/motifs as reflected in the search against the current NCBI Conserved Domain 
Database (CDD). However, by using the Rapid Automatic Detection and Alignment of 
Repeats (RADAR) [24] at the European Bioinformatics Institute (EBI), a specific region 
(amino acid residues 1107-1464), which was composed of eight tandem repeated sequences, 
was identified within the human α-synemin tail domain, but absent within the β-synemin tail 
domain (Fig. 6A). Interestingly, the amino acid sequence from the start of the second repeat 
to the end of the last repeat is the primary sequence of SNTIII, i.e., the 312 amino acid insert 
present only in the human α-synemin isoform. Each repeat within SNTIII contains a unique 
sequence motif of Ser/Thr-X-Arg-His/Gln (S/T-X-R-H/Q, where X represents any of the five 
amino acid residues V, G, I, F, L) (Fig. 6A). Furthermore, similar tandem repeated sequences 
are also present in synemins from different species, such as mouse H-synemin and chicken 
synemin (both considered orthologs of human α-synemin) as shown in the RADAR output 
results in Fig. 6, B and C, respectively. Surprisingly, the tandem repeat sequences of the 
chicken synemin ortholog is more similar to the human tandem repeats than is that of the 
mouse H-synemin. However, in terms of the entire protein sequences, the overall homology 
of the mouse H-synemin compared to the human α-synemin (67% identity, 78% homology) 
is higher than that of the chicken synemin to human α-synemin (35% identity, 53% 
homology). Multiple sequence alignment of the primary sequences of human α-synemin, 
mouse H-synemin, and chicken synemin using CLUSTAL W [32] and MULTALIN [33] also 
revealed that most of the S/T-X-R-H/Q motifs are conserved among the different species (Fig. 
6D). Secondary protein structure prediction for SNTIII was also performed using the 
PROFPHD at the PredictProtein Server [23, 34]. The results showed that the secondary 
structure of SNTIII contains 0% α-helix, 45% β-strands, and 55% random loops. 
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Interestingly, the S/T-X-R-H/Q motifs are all present within the predicted β-strands (Fig. 
6A).  
 
Discussion 
We have identified and characterized the direct interaction of human synemin with the 
cytoskeletal protein talin. In the co-immunoprecipitation experiment (Fig. 2A), both human 
α- and β-synemin isoforms were precipitated along with the talin from the human uterine 
smooth muscle cell extracts, indicating close association of the human synemins with talin 
within living muscle cells. This result is in agreement with a recent study, which reported 
co-immunoprecipitation of talin with synemin from human hepatic stellate cell extracts [35]. 
Subsequent protein-protein interaction assays using recombinant protein regions of both talin 
and human synemin isoforms identified that a specific region within the talin rod domain (R2) 
interacts directly with SNTIII, the 312 amino acid insert present only within the human 
α-synemin isoform (Fig. 2, B-D). No interaction of human β-synemin regions with talin 
regions were observed, indicating that α-synemin is the only isoform that interacts with talin. 
Precipitation of β-synemin in the Co-IP experiment (Fig. 2A) may result from the direct 
association of β-synemin with α-synemin, or from the indirect association with other IF 
proteins (e.g., vimentin) that associate with α-synemin via their conserved rod domains. It is 
generally known that the rod domain of IF proteins mediate α-helical coiled-coil formation 
and IF assembly [36, 37].  
We previously reported that SNTIII also interacts with vinculin [27], another important 
cytoskeletal protein, and is present in both cell-cell and cell-extracellular matrix 
adherens-type junctions [38-40]. Talin is found primarily within cell-extracellular matrix 
adherens-type junctions [20, 41]. In the present study the talin R2 region exhibited a similar 
affinity for SNTIII as did the vinculin tail (VT) in the solid phase ELISA binding assays (Fig. 
3A). Also, talin R2 competed with VT in binding to SNTIII (Fig. 3B). These results suggest 
that human α-synemin does not bind simultaneously to both vinculin and talin. Interestingly, 
talin also contains multiple vinculin binding sites within its extended rod domain, several of 
which are located within the talin R2 region [42]. Thus, it is possible that multiple synemin 
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molecules bind with multiple talin and vinculin molecules, thereby forming protein 
complexes that provide structural support for living muscle cells (Fig. 7). 
  Results of confocal microscopy studies provided additional evidence regarding the 
interaction of synemin and talin within human skeletal muscle cells. Synemin and talin 
co-localized within the costameric structures located periodically along and subjacent to the 
sarcolemma (Fig. 4). In addition, EGFP-tagged SNTIII co-localized with DsRed-tagged talin 
R2 at the focal adhesion sites within transfected A-10 cells. These results in toto indicate an 
intracellular association between human synemin and talin.  
  We have identified for the first time that there is a region within the tail domain of human 
α-synemin containing eight tandem repeated sequences. Seven of these tandem repeats 
comprise the entire region of SNTIII. Furthermore, each of these seven repeats contains a 
specific S/T-X-R-H/Q motif, in which the arginine residues are highly conserved. 
Additionally, similar regions containing tandem repeats and motifs similar to the 
S/T-X-R-H/Q motifs are also present in synemins of differing species, suggesting these 
repeats have been conserved in evolution. A recent study of molecular evolution of type VI 
IF proteins showed that nestin, tanabin, and transitin all contain a repeated domain within 
their C-terminal tail [43]. Thus, our findings also provide additional support for classification 
of synemin as a type VI IF protein. 
Overall, the results of this study show that the 312 amino acid insert (SNTIII), which is 
present only in human α-synemin, interacts specifically with a region (R2) within the long 
rod domain of the cytoskeletal protein talin. That SNTIII interacts with both vinculin and 
talin may be reflected by its unique primary sequence, which is composed of seven tandem 
repeats containing unique S/T-X-R-H/Q motifs. Our results indicate that the additional 312 
amino acid insert confers extra functions for the human α-synemin isoform. Both vinculin 
and talin are actin-binding proteins [19, 40] that are present within adherens-type junctions, 
such as the costameres in striated muscle cells. Thus, our results suggest that human 
α-synemin, via its interaction with either vinculin or talin, is able to link the desmin/synemin 
heteropolymeric IFs to the muscle cell sarcolemma, and thereby helps provide overall 
integration of the contractile apparatus within mammalian muscle cells. 
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Figure 1. Schematic diagram of human synemin and talin, and the constructs used in the in vitro 
binding studies. A, Human synemin molecule and the three synemin constructs (SNTless, SNβT, and 
SNTIII). Synemin is composed of a short, ten-amino acid head domain (H), a conserved central 310 
amino acid rod domain (Rod), and a long C-terminal tail domain (Tail). Human α- and β-synemin 
sequences are identical with the exception that α-synemin contains an additional 312 amino acid 
insert (SNTIII, ~33 kDa) located near the end of the long C-terminal tail. The entire β-synemin tail 
(SNβT, amino acid residues 322-1251, ~102 kDa) was cloned into the pFLAG-ATS vector as a 
FLAG-tagged fusion protein. SNTless (amino acid residues 1-329, ~37 kDa) was cloned into the 
pMALC2X vector as an MBP fusion protein. SNTIII was cloned into both the pFLAG-ATS vector 
and the PMALC2X vector as a FLAG-tagged fusion protein and an MBP-tagged fusion protein, 
respectively. B, Schematic diagram of human talin and the GST talin constructs.  
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Figure 2. The 312 amino acid insert (SNTIII) within human α-synemin interacts directly with 
the rod domain of talin. A, Co-immunoprecipitation of human synemin isoforms with talin by 
anti-talin 8d4 mAb from UTSMC extracts. Lys denotes the load of the UTSMC lysates. Both α- and 
β-synemins were precipitated along with talin. B, Blot overlay assays using GST-tagged talin fusion 
proteins and the positive control of GST-VT overlaid with each of the purified synemin recombinant 
proteins. GST alone served as a negative control. The migration position of each GST-tagged talin 
fusion protein on the blot is marked with an asterisk. SNTIII interacts with both the talin R2 and VT, 
whereas SNβT and SNTless did not. C, GST pull-down assays. GST-talin R2 was immobilized on 
glutathione agarose and incubated with purified FLAG-SNTIII. GST alone and beads alone served as 
negative controls. Immobilized GST-talin R2 precipitated FLAG-SNTIII, whereas GST alone or 
beads alone did not. D, Dot blot overlay assays using GST-talin R2 and the positive control of 
GST-VT overlaid with purified MBP-tagged SNTIII. A duplicate membrane overlaid with MBP alone 
served as a negative control. SNTIII interacts specifically with the talin R2 and the VT. 
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Figure 3. Talin R2 interacts with SNTIII and competes with the VT in binding to SNTIII. A, 
Ninety six-well plates coated with 100 nM purified GST-talin R2 (squares), GST-VT (circles), or GST 
alone (triangles) were incubated with increasing concentrations of purified FLAG-SNTIII for 1 h at 
25°C. After extensive washing, the bound SNTIII was detected with HRP-conjugated anti-FLAG 
mAb and the HRP substrate 2,2'-azino-bis-[3-ethylbenzthiazoline-6-sulfonic acid] (ABTS) by 
measurement at A405. Background A405 values of wells incubated with buffer only were subtracted. 
The resulting A405 values were plotted versus the concentrations of incubated purified FLAG-SNTIII. 
The values represent the mean ± s.d. from three independent experiments. The data were then fitted 
to a moving average trendline with a period of 2. Interactions of talin R2 and VT with SNTIII were 
both saturable, with estimated KD values of 52 ± 11 nM and 30 ± 8 nM, respectively. B, 
Increasing concentrations of GST-VT, along with 400 nM purified FLAG-SNTIII, were added to a 
96-well plate coated with GST-talin R2, and incubated for 1 h at 25°C. Bound SNTIII was then 
determined as described in A. Values represent the mean ± s.d. from three independent experiments. 
The data were then plotted versus the concentration of GST-VT, and fitted to a moving average 
trendline with a period of 2. VT competes with talin R2 for binding to SNTIII.  
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Figure 4. Confocal microscopy studies indicate synemin colocalizes with talin within human 
adult skeletal muscle cells. A-C, Confocal microscopy analysis of the localization of synemin and 
desmin within longitudinal sections of human skeletal muscle. Synemin was labeled green with 
anti-synemin 2856 pAb and secondary Alexa Fluoro 488 goat anti-rabbit IgG. Desmin was labeled red 
with anti-desmin DEU-10 mAb, followed by staining with secondary Alexa Fluoro 594 goat 
anti-mouse IgG. Synemin colocalized with desmin at the myofibrillar Z-lines (C). D-I, Confocal 
microscopy analysis of synemin and talin within human skeletal muscle. Synemin was labeled green 
with anti-synemin 2856. Talin was labeled red with anti-talin 8d4 mAb. In cross sections (D-F), 
synemin colocalized with talin along the sarcolemma (F). In longitudinal sections (G-I), synemin 
colocalized with talin within the costameres (I, small window, arrows). (Bars, 25 μm) 
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Figure 5. SNTIII co-localizes with talin as well as with talin R2 at FA sites within transfected 
A-10 cells. A-D, A-10 cells were transfected with EGFP-SNTIII plasmids. Talin was then labeled red 
24 hours post transfection with anti-talin 8d4 mAb plus secondary Alexa fluoro 594 goat anti-mouse 
IgG. B-D represents the boxed area in A. SNTIII co-localized with talin within FAs (A and D). E-H, 
A-10 cells were transfected with EGFP-SNβT plasmids. F-H represent the boxed area in E. SNβT did 
not co-localize with talin at the FA sites labeled by anti-talin 8d4 mAb. I-L, A-10 cells were 
co-transfected with EGFP-SNTIII and DsRed-talin R2 plasmids. J-L represents the boxed area in I. 
SNTIII co-localized with talin R2 at FA sites. (Bars, 15 μm) 
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Figure 6. SNTIII is composed of seven tandem repeats. Analysis of the primary sequences of 
human α-synemin, mouse H-synemin, and chicken synemin using Rapid Automatic Detection and 
Alignment of Repeats (RADAR) at the European Bioinformatics Institute (EBI) identified a similar 
domain containing tandem repeated sequences within the C-terminal tail of each synemin ortholog. 
The relative position of each repeat within the amino acid sequence of each synemin ortholog is 
shown at the left side of the alignment. The well aligned residues are boxed. A, The repeated domain 
(amino acid residues 1107-1464) within the human α-synemin tail. SNTIII (amino acid residues 
1153-1464) comprises the last seven repeats. A sequence motif of S/T-X-R-H/Q (where X represents 
any of the five amino acid residues of V, G, I, F, L) within each repeat of the SNTIII is well aligned. 
Secondary structure prediction using PROFPHD for each repeat is shown at the top of the alignment. 
The dashed lines with arrows denote β-strands (β1). All of the S/T-X-R-H/Q motifs are within the 
predicted β-strands. B and C, The repeated domain identified within the mouse H-synemin tail (B) 
and the chicken synemin tail (C), respectively. The well aligned arginine residues (3 lysines instead of 
arginines in chicken synemin) are marked with asterisks. D, Alignment of the amino acid sequences 
corresponding to human, mouse, and chicken SNTIII using MULTALIN. The conserved 
S/T-X-R-H/Q motifs are boxed in the resulting consensus sequence. At least five of the seven 
S/T-X-R-H/Q motifs are conserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Schematic diagram showing that desmin/synemin heteropolymeric IFs are linked to 
the costameric protein assemblies. The green ovals within the α-synemin tail domains represent the 
312 amino acid insert. Different α-synemin molecules are shown interacting with talin and vinculin, 
which attach the desmin/synemin heteropolymeric IFs to the costameres. The rod domains and tail 
domains of both α- and β-synemins are able to interact with α-dystrobrevin and dystrophin, 
respectively, which represents an alternative way of attaching the desmin/synemin heteropolymeric 
IFs to the costameres. 
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Abstract 
Synemin is a very unique cytoplasmic intermediate filament protein with limited 
understanding of its exact cellular functions. The single human synemin gene encodes at least 
two splice variants named α-synemin and β-synemin, with the larger α-synemin containing 
an additional 312 amino acid insert within the C-terminal tail domain. We report herein that, 
by using the entire tail domain of the smaller β-synemin as the bait in a yeast two-hybrid 
screen of a human skeletal muscle cDNA library, the LIM domain protein zyxin was 
identified as an interaction partner of human synemin. Co-immunoprecipitation of synemin 
and zyxin from lysates of cultured cells provided additional evidence for in vivo association 
of these two proteins. Synemin binding site in human zyxin was subsequently mapped to the 
C-terminal three tandem repeats of the LIM domains, whereas the binding site for zyxin 
within β-synemin was within the C-terminal 332 amino acid region (SNβΤΙΙ) at the end of 
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the tail domain. Transient expression of SNβΤΙΙ markedly reduced the zyxin protein level 
within mammalian cells and blocked localization of zyxin at the focal adhesion sites. 
Knockdown synemin expression with siRNAs within Hela cells resulted in significantly 
compromised cell adhesion and cell motility. Our results suggest that synemin participates in 
focal adhesion dynamics and is essential for cell adhesion and migration. 
 
Introduction 
Intermediate filaments (IFs) are ~10 nm in diameter, filamentous cytoskeletal polymers that 
provide crucial structural support within mammalian cells (Erber et al., 1998). In addition to 
the traditional mechanical scaffolding role, recent studies indicated that IFs may have novel 
functions in many important cellular processes such as cell adhesion/migration, signal 
transduction, targeting of proteins and lipids, and organization of subcellular organelles 
(Ivaska et al., 2007; Kim and Coulombe, 2007). The IFs, which are heterogeneous in nature, 
are composed of cell-type specific intermediate filament (IF) proteins (Fuchs and Weber, 
1994; Coulombe and Wong, 2004; Omary et al., 2004). In humans, more than 67 IF genes 
encoding individual IF proteins have been identified, all of which compose the IF protein 
superfamily (Hesse et al., 2001). 
Synemin is a very large, unique member within the IF protein superfamily. The molecular 
structure of the synemin molecule is characteristic of an IF protein, with a central 312 amino 
acid conserved α-helical rod domain flanked by a very short, 10 amino acid N-terminal head 
domain and a very long, ~1000 amino acid C-terminal tail domain (Becker et al., 1995; 
Bellin et al., 1999). Although first discovered within muscle cells (Granger and Lazarides, 
1980), synemin is also found expressed in many non-muscle cells and some types of cancer 
cells. These include vertebrate erythrocytes (Granger and Lazarides, 1982; Granger et al., 
1982), lens cells (Granger and Lazarides, 1984; Tawk et al., 2003), normal and malignant 
astrocytes (Sultana et al., 2000; Jing et al., 2005; Jing et al., 2007), glia and neurons 
(Izmiryan et al., 2006), hepatic stellate cells (Uyama et al., 2006), human hepatoma cells (Liu 
et al., 2004), human malignant biliary epithelial cells (Schmitt-Graeff et al., 2006), and even 
cultured Hela cells (Olsen et al., 2006), which is a human cervix epithelial adenocarcinoma 
cell line. The wide expression profile of synemin, and particularly, expression in cancer cells, 
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suggests that synemin has important, fundamental cellular function. 
Synemin is not able to self-assemble into homopolymeric filaments in vivo (Bellin et al., 
1999; Titeux et al., 2001; Xue et al., 2004; Jing et al., 2007). Association of synemin with the 
major type III IF proteins, such as desmin and/or vimentin, through the conserved α-helical 
rod domains forms heteropolymeric IFs within mammalian cells (Robson et al., 2004). 
Synemin also interacts with non-IF proteins α-actinin (Bellin et al., 1999; Bellin et al., 2001), 
vinculin (Bellin et al., 2001; Sun et al., 2008a), talin (Uyama et al., 2006; Sun et al., 2008b), 
α-dystrobrevin (Mizuno et al., 2001), dystrophin/utrophin (Bhosle et al., 2006), as well as 
protein kinase A (Russell et al., 2006). Thus, synemin seems to be capable of linking the 
heteropolymeric synemin/desmin or synemin/vimentin IFs to various subcellular structures 
via interactions with those non-IF protein binding partners. 
The single human synemin gene encodes two splice variants named α-synemin (180 kDa 
by SDS-PAGE; 172.7 kDa from sequence) and β-synemin (150 kDa by SDS-PAGE; 140.1 
kDa from sequence) (Titeux et al., 2001). The larger α-synemin, with the only difference of 
an additional 312 amino acid insert near the end of the long C-terminal tail domain, is 
identical to the smaller β-synemin (Titeux et al., 2001). In previous studies, we have shown 
that the 312 amino acid insert within α-synemin interacts with human vinculin/metavinculin 
and talin, thereby conferring extra functions for the larger α-synemin (Sun et al., 2008b; Sun 
et al., 2008a). However, the possible role(s) of the smaller β-synemin within living cells 
remained unclear.  
  Using the entire tail domain of human β-synemin (SNβT) as the bait, zyxin was identified 
as a binding partner of synemin in a yeast two-hybrid screen of a human skeletal muscle 
cDNA library. Zyxin is a LIM domain protein present primarily at sites of actin-membrane 
interactions (Beckerle, 1986; Crawford and Beckerle, 1991; Kadrmas and Beckerle, 2004). 
Several lines of evidences suggest that zyxin plays important roles in regulating cell adhesion 
and migration, actin filament assembly, and in nucleus-cytoplasm communications (Beckerle, 
1986; Nix and Beckerle, 1997; Nix et al., 2001; Yoshigi et al., 2005; Hansen and Beckerle, 
2006; Hoffman et al., 2006). Our results suggest that, via direct interaction with zyxin, 
synemin participates in actin cytoskeleton dynamics within living cells and is essential for 
cell adhesion and migration. 
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Materials and Methods 
Generation of cDNA Constructs 
The human α- and β-synemin cDNAs were described previously (Titeux et al., 2001). For 
yeast two-hybrid assays, human synemin cDNA fragments encoding amino acid residues 
321-579 (SNTIa), 580-920 (SNTIb), 1153-1464 (SNTIII), 922-1253 (SNβTII), 922-1565 
(SNαTII), and the entire tail domain of β-synemin (SNβT, amino acid residues 322-1253) 
(Fig. 2D) were amplified by PCR and were introduced into the yeast two-hybrid bait vector 
pDEST32 (Invitrogen) by Gateway Recombination Technology using LR Clonase 
(Invitrogen). The human zyxin cDNA fragment encoding amino acid residues 1-383 (Zyx 
1-383) was PCR amplified from the Human 3-Frame Skeletal Muscle cDNA Library 
(Invitrogen) and was cloned into the yeast prey vector pDEST22 (Invitrogen). The resulting 
plasmids were all sequenced in the DNA Sequencing and Synthesis Facility at Iowa State 
University, and were all confirmed in frame with the DNA binding domain (DB, pDEST32 
constructs) or the activation domain (AD, pDEST22 constructs) of the Gal4 protein.  
For expression of recombinant proteins, the cDNA fragments encoding SNTIa, SNTIb, 
SNTIII, SNβTII, and SNβT were PCR amplified and subcloned into the pFLAG-ATS 
expression vector (Sigma) at 5’ Hind III and 3’ Bgl II sites as FLAG-tagged expression 
constructs. The cDNA fragments encoding full-length human zyxin (Zyx 1-572, amino acid 
residues 1-572), Zyx 1-383, and the three zyxin LIM domains (Zyx 375-572, amino acid 
residues 375-572) were PCR amplified from the Human 3-Frame Skeletal Muscle cDNA 
Library and were subcloned into the pGEX-4T2 GST expression vector (GE Healthcare) at 5’ 
BamH I and 3’ Xho I sites. All the expression constructs were confirmed accurate by 
automated sequencing in the DNA Sequencing and Synthesis Facility at Iowa State 
University. 
 
Yeast Two-Hybrid Screening  
Yeast Two-hybrid screening was performed following instructions of the ProQuest 
Two-Hybrid System with Gateway Technology manual (Invitrogen). Briefly, 10 μg of both 
the pDEST32-SNβT plasmids and the human 3-frame skeletal muscle cDNA library were 
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co-transformed into the yeast strain MaV203, plated onto the SC-Leu-Trp-His plates 
containing 25 mM 3-aminotriazole (3-AT), and incubated for 72 hr at 30oC. Plates containing 
growing yeast colonies were replica-cleaned and incubated for another 48 hr at 30oC. Each of 
the resulting yeast colonies growing on the selective plates was then streaked onto a fresh 
SC-Leu-Trp plate and incubated at 30oC for 48 hr. Plasmids were isolated from the positive 
yeast clones and were sequenced using the sequencing primer pair for the pDEST22 vector. 
To confirm the positive interactions, the identified pDEST22 plasmids containing zyxin 
cDNA fragments were co-transformed with the pDEST32-SNβT plasmids into the MaV203 
yeast cells. Five master plates were then created by streaking the colonies onto SC-Leu-Trp 
plates along with the five yeast control strains (controls A-E) (Invitrogen) and the two 
self-activation control yeast strains (the “bait only” control containing DB-SNβT plus empty 
AD vectors and the “prey only” control containing AD-Zyx 1-572 plus empty DB vectors). 
The master plates were then patched onto Whatman filter paper # 541 for X-gal assays, and 
were replica-plated onto plates of SC-Leu-Trp-Ura, SC-Leu-Trp containing 0.2% 5-fluoorotic 
acid (5-FA), and of SC-Leu-Trp-His containing 100 mM 3-AT for observation of growth 
phenotypes. 
 
β-Galactosidase Liquid Culture Assays 
β-Galactosidase liquid culture assays using chlorophenol red-β-D-galactopyranoside (CPRG) 
(Roche Diagnostics) as the substrate were performed following instructions of the Clontech 
Yeast Protocol Handbook (Clontech, 2000). The yeast control stains (controls A-E) used in 
the assays came from the ProQuest Two-Hybrid System with Gateway Technology Kit 
(Invitrogen). These five controls represented increasing strength of interactions in the 
β-Galactosidase liquid culture assays and served as the standards. The experiments were 
performed in triplicates and the calculated mean of β-galactosidase units ± S.D. for each 
assay was plotted using Microsoft Excel.  
 
Expression and Purification of Recombinant Proteins 
Recombinant proteins were all expressed in E.coli BL21-Codon Plus (DE3) bacterial cells 
(Stratagene). FLAG-tagged synemin fusion proteins were affinity purified using Anti-FLAG 
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M2-Agarose Affinity Gel (Sigma). GST-tagged zyxin fusion proteins were batch purified 
using Glutathione Agarose (Sigma).  
 
Antibodies 
The anti-synemin 2856 polyclonal antibody (pAb) has been described previously (Bellin et 
al., 1999). Anti-vimentin monoclonal antibody (mAb) V9, horseradish peroxidase (HRP) 
conjugated anti-FLAG M2 mAb, anti-α-tubulin mAb, and anti-vinculin mAb hVIN-1 were 
purchased from Sigma. Anti-GFP pAb and HRP conjugated anti-GST mAb were obtained 
from Santa Cruz Biotechnology. Anti-human zyxin mAb, Alexafluor secondary antibodies, 
and Alexafluor-594 phalloidin were obtained from Invitrogen. Anti-VASP mAb were 
obtained from BD Biosciences. 
 
Co-Immunoprecipitation (Co-IP), FLAG Immunoprecipitation, and GST Pull-Down Assays 
For Co-IP assays, 1x107 Hela cells were lysed with the MPER Mammalian Protein Extraction 
Reagent (Pierce) and incubated with 5 μg anti-human zyxin mAb for 1 hr at 4°C. Fifty μl 
25% Protein A/G Plus Beads (Santa Cruz Biotechnology) were then added to the reaction for 
incubation of another 1 hr at 4°C. The same amount of Hela cell lysates incubated with 5 μg 
anti-GAPDH mAb (Cell Signaling) plus 50 μl Protein A/G Plus Beads, or with 50 μl beads 
alone, were served as two negative controls. The reactions were washed twice with 1× PBS 
and then eluted with 2× SDS sample buffer. The resulting eluates were subjected to 
SDS-PAGE and analyzed by Western blotting with anti-synemin 2856 pAb, and then 
reprobed with anti-human zyxin mAb.  
FLAG immunoprecipitation assays were performed following instructions of the 
Anti-FLAG M2 Affinity Gel manual (Sigma). Briefly, 4 μg of each GST-tagged zyxin fusion 
protein was incubated in 500 μl 1× PBS containing 4 μg purified FLAG-SNβT and 40 μl of 
the pre-cleaned Anti-FLAG M2 beads for 3 hr at 4°C. The beads were then centrifuged, 
washed twice with 1× PBS containing 0.1% Tween-20 (PBST), and eluted with 2× SDS 
sample buffer. The resulting eluates were subjected to SDS-PAGE and analyzed by Western 
blotting with HRP conjugated anti-GST mAb and HRP conjugated anti-FLAG M2 mAb. 
GST-pull down assays were performed essentially as previously described (Sun et al., 
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2008a). 
 
Surface Plasmon Resonance 
Surface plasmon resonance was performed using Biacore T100 (GE Healthcare) in the 
Proteomics Facility at Iowa State University. Purified GST-Zyx 1-572 fusion protein was 
immobilized on the activated flowcell 2 of a CM5 sensor chip using the GST Capture Kit 
(GE Healthcare) at an Rmax value of ~100. GST alone immobilized on the activated flowcell 
1 served as a reference in the experiments. Increasing concentrations (from 250 nM to 3000 
nM) of purified FLAG-SNβT were then injected over the flowcells for an association phase 
of 180 sec at a flow rate of 10 μl/min and followed by a 100 sec disassociation phase. The 
protein-protein interactions were then detected in realtime by the Biacore T100 control 
software (GE Healthcare). The resulting sensorgrams, as well as affinity of the interaction, 
was analyzed by the Biacore T100 evaluation software (GE Healthcare) using the reference 
subtracted (flowcell 2-1) data sets.  
 
Cell Culture 
Hela cells were kindly provided by Dr. Marit Nilsen-Hamilton at Iowa State University. A-10 
cells, a rat vascular smooth muscle cell line, were purchased from American Type Culture 
Collection (ATCC). Human uterine smooth muscle cells (UTSMC) were obtained from 
Lonza. Hela cells and A-10 cells were maintained with Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) at 37°C (95% air, 5% CO2). 
Human UTSMC cells were maintained with Smooth Muscle Medium-2 Bulletkit (Lonza) at 
37°C with 95% air and 5% CO2. 
 
Immunofluorescence, Transfection Studies, and Flowcytomery 
Immunofluorescence staining of cultured cells were performed essentially as previously 
described (Sun et al., 2008a). For transfection studies, cells that seeded on collagen-coated 
coverslips with optimal confluence were transfected with mammalian expression constructs 
using JetPEI Transfection Reagent (Polyplus Transfection). Cells were then immunostained 
with appropriate primary and Alexafluor secondary antibodies. Immunofluorescence 
 86
microscopy was conducted using a LEICA DEMIRE2 inverted microscope equipped with a 
CCD camera in the Hybridoma Facility at Iowa State University. Cells that express 
EGFP-SNβTII were collected by flow cytometry using a Beckman Coulter EPICS Altra Flow 
Cytometer in the Hybridoma Facility at Iowa State University.  
 
RNA Interference and Quantitative-PCR 
The Hs_Dmn_4_HP siRNA specific for both human α- and β-synemins and the Alexa Fluor 
488 Labeled Negative Control siRNA were obtained from Qiagen. Hela cells cultured in 
6-well plates (Corning COSTAR) were transfected with 5 nM of the each siRNA using the 
HiPerFect Transfection Reagent (Qiagen). Total RNA and cDNA of the siRNA treated Hela 
cells were then prepared 72 hr post transfection using the RNeasy Mini Kit (Qiagen) and the 
QuantiTect Reverse Transcription Kit (Qiagen), respectively, following the manufacturer’s 
instructions. Quantitative-PCR measuring synemin mRNA level was done with 
Hs_Dmn_1_SG QuantiTect Primer Assay (Qiagen) using a Stratagene Mx4000 Multiplex 
Quantitative PCR System (Stratagene) in the DNA Sequencing and Synthesis Facility at Iowa 
State University. Protein expression levels were analyzed by Western blotting using 
appropriate antibodies 72 hr post transfection of the siRNAs. 
 
Cell Adhesion and Migration Assays 
Cell adhesion assays were performed as previously described (Zhang et al., 2006) with 
modifications. Briefly, 1×105 Hela cells that had been treated for 72 hr with 5 nM of the 
Alexa Fluor 488 Labeled Negative Control siRNA or with 5 nM of the Hs_Dmn_4_HP 
siRNA were seeded onto wells of a 12-well CellBIND surface tissue culture microplate 
(Corning Life Sciences) for 1 hr. Cells were then washed gently with 1xPBS for 5 times, 
detached from the plate with 0.25% Trypsin-EDTA, and counted with the Guava Viacount 
(Guava Technology) at the Hybridoma Facility at Iowa State University. The experiments 
were performed in triplicates. The adhesion rate was calculated as number of adherent 
cells/1×105. Data were plotted using Microsoft Excel. The 2-D wound healing assay and the 
3-D migration modified Boyden chamber assay using non-coated transwell inserts (6.5 mm 
24-well format with 8 μm pore size, Corning Life Sciences) were performed essentially as 
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previously described (Kleeberger et al., 2007). For the modified Boyden chamber assay, 
1×105 Hela cells that had been treated with siRNAs for 72 hr were seeded on the upper side 
of the membrane of the transwell inserts within serum free DMEM media, while DMEM 
media containing 10% FBS was added at the bottom side. After incubation for 48 hr at 37°C, 
cells were fixed with 2% formaldehyde in 1× PBS and stained with 1.67 mmol/L CellTrace 
Calcein AM (Invitrogen). Cells on the upper side of the membranes were then removed by 
gently scrapping with a wet cotton swab. The resulting membranes were then cut out of the 
transwell inserts, mounted on glass slides with Vectashield Mounting Medium (Vector 
Laboratories), and were observed under the microscope. Numbers of cells from 5 different 
high-power fields (HPF) (20× objective) on each membrane from triplicate experiments were 
counted. Data (mean ± S. D.) were plotted with Microsoft Excel. 
 
Results 
Zyxin Was Identified to Interact with Synemin by Yeast Two-Hybrid Screening Using SNβT as 
the Bait 
The hypervariable N-terminal head and C-terminal tail domains of IF proteins often are the 
regions mediating interactions with non-IF protein binding partners (Green et al., 2005; Kim 
and Coulombe, 2007). In the case of the large type VI IF protein synemin, it contains a very 
short, 10 amino acid head domain and a very long, ~1000 amino acid tail domain. Thus, 
chances are that the long tail domain of synemin harbors most of the binding sites for its 
putative non-IF protein interaction partners. To identify novel proteins that interact with 
synemin, the entire tail domain (amino acid residues 322-1253) of human β-synemin was 
used as the bait (DB-SNβT) in a yeast two-hybrid screen of a human skeletal muscle cDNA 
library. A total of approximately 2 × 106 transformants were screened and resulted in 15 
positive colonies growing on SC-Leu-Trp-His plates containing 25 mM 3-aminotriazole. 
Nine of them hosted prey plasmids containing cDNA fragments encoding various regions of 
human zyxin in frame with the Gal4 activation domains. Interestingly, these zyxin regions 
exactly constituted a series of N-terminal deletions of the full-length zyxin, with the smallest 
one (Zyx 375-572) representing the three tandem repeats of the LIM domains at the 
C-terminal end of human zyxin (Fig. 1A).  
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Yeast two-hybrid screening sometime resulted in false positives. In addition, although 
there is no evidence that the LIM domains of zyxin can bind directly to double strand DNA, a 
well list of transcription factors containing specific LIM domains have been shown to be able 
to do so (Matthews and Sunde, 2002), which may directly activate the reporter genes of the 
yeast two-hybrid system. To exclude the possibility that our results obtained from the yeast 
two-hybrid screening were false positives, the MaV203 yeast cells were co-transformed with 
each AD-Zyxin construct plus the DB-SNβT plasmid, and interactions were then tested using 
the three reporter genes (LacZ, His3, and Ura3) of the ProQuest yeast two-hybrid system. 
The five control yeast strains (Controls A-E, ProQuest yeast two-hybrid system), as well as 
the self-activation controls of the bait only (DB-SNβT plus AD vector) and the prey only 
(AD-Zyx 1-572 plus DB vector) were also included. Similar to the positive controls 
(Controls B-D), the yeast strains containing various AD-Zyxin constructs plus DB-SNβT 
demonstrated strong β-galactosidase activities, grew vigorously on SC-Leu-Trp-Ura and 
SC-Leu-Trp-His + 100 mM 3-AT selective plates, and exhibited inhibited growth on 
SC-Leu-Trp-Ura plates containing 0.2% 5-Fluoroorotic acid. In contrast, the negative control 
(DB vector plus AD vector) and the two self-activation controls (DB-SNβT plus AD vector 
and AD-Zyxin 1-572 plus DB vector) showed phenotypes contrary to the positive controls 
(Fig. 1B). Therefore, these results confirmed that the interaction of SNβT with zyxin regions 
within the yeast two-hybrid system were not false positives. Furthermore, the primary 
binding site for synemin on zyxin could be within the three tandem repeats of the LIM 
domains. 
Interaction of synemin with zyxin was further illustrated by CO-IP assays. Hela cells were 
used for the CO-IP assays because they express synemin (Olsen et al., 2006) and are 
relatively easy to handle with. As shown in Fig. 1C, synemin was specifically precipitated 
along with zyxin by immobilized anti-human zyxin mAb from the Hela cell lysates. Lack of 
β-synemin in the lane of CO-IP with anti-human zyxin mAb may result from a very small 
amount of β-synemin precipitated, and thereby could not be detected by Western blotting. In 
toto, this result indicated an in vivo association of human synemin with zyxin. 
 
Mapping the Synemin Binding Site in Human Zyxin 
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To confirm the binding site of synemin in zyxin and to provide quantitative estimates of the 
interactions, co-transformants of DB-SNβT plus each zyxin region in AD vector (AD-Zyx 
1-572, AD-Zyx 82-572, AD-Zyx 197-572, AD-Zyx 375-572, and AD-Zyx 1-383) were 
analyzed for β-galactosidase activity with liquid culture assays using CPRG. These AD-Zyxin 
constructs represented overlapping regions which together include the full length amino acid 
sequence of zyxin (Fig. 2A). The five control yeast strains (controls A-E) with interaction 
strengths ranging from none (control A, DB vector plus AD vector) to very strong (control E, 
AD vector plus DB-full length Gal4) were also included in the assay as standards to indicate 
relative interaction strengths. The co-transformant of DB-SNβT plus AD vector served as a 
negative control. As shown in Fig. 2B, human zyxin regions Zyx 1-572, Zyx 82-572, Zyx 
197-572, and Zyx 375-572 all showed positive interactions with SNβT as compared to the 
positive, weak interaction control B (DB-human RB + AD-human E2F1). In contrast, zyxin 
region 1-383 did not show any interaction with SNβT, confirming that the zyxin LIM 
domains are required for zyxin/synemin interaction. In addition, interaction of the full-length 
zyxin (Zyx 1-572) with SNβT displayed relatively moderate interaction strength as compared 
to the control C (DB-Drosophila DP + AD-Drosophila E2F) which represented a 
moderate-strong interaction. Interestingly, deleting the N-terminal 81 amino acids of zyxin 
(Zyx 82-572) resulted in an even higher affinity for SNβT than that of the full length zyxin 
(Zyx 1-572). This may reflect an intramolecular interference caused by the N-terminal 81 
amino acids of zyxin in its interaction with human synemin. In comparison with other zyxin 
regions, the zyxin LIM domains (Zyx 375-572) displayed relatively weak interaction with 
SNβT, indicating that sequences in the zyxin N-terminal region are required for the optimal 
interaction with SNβT.  
  Interactions of different zyxin regions with SNβT were also examined in vitro by 
immunoprecipitation assays. GST-tagged full-length zyxin (GST-Zyx 1-572) and zyxin LIM 
domains (GST-Zyx 375-572), but not the N-terminal 383 amino acids of zyxin (GST-Zyx 
1-383), were specifically precipitated by FLAG-SNβT immobilized on anti-FLAG M2 resins 
(Fig. 2C). These results were consistent with the results obtained from the yeast two-hybrid 
β-galactosidase liquid culture assays (Fig. 2B) and further confirmed that the zyxin LIM 
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domains contain the binding site for synemin. 
 
Mapping the Zyxin Binding Site in Human Synemin 
To narrow down the binding site for zyxin in human synemin, SNβT was further divided into 
three consecutive regions named SNTIa, SNTIb, and SNβTII as diagrammed in Fig. 2D. The 
312 amino acid insert present only in α-synemin (SNTIII) and the region includes both 
SNβTII and SNTIII in the α-synemin tail (SNαTII) (Fig. 2D) were also included in the 
mapping study to examine whether they interact with zyxin. The cDNAs encoding SNTIa, 
SNTIb, SNβTII, SNTIII and SNαTII were introduced into the yeast two-hybrid DB vectors 
and were co-transformed with AD-Zyx 82-572 plasmids into the MaV203 yeast cells. 
Interactions were examined using β-galactosidase liquid culture assays. Co-transformants of 
DB-SNβT plus AD-Zyx 82-572 and of DB vector plus AD-Zyx 82-572 served as the positive 
control and the negative control, respectively. As shown in Fig. 2E, SNβTII displayed very 
strong interaction with zyxin as compared with the positive control. SNTIa, SNTIb and 
SNTIII did not interact with zyxin. These results demonstrated that the binding site for zyxin 
in synemin is within the C-terminal 332 amino acids at the end of the β-synemin tail domain. 
SNαTII showed similar interaction strength as SNβT does (Fig. 2E), indicating that presence 
of the 312 amino acid insert within α-synemin tail does not abolish the interaction. Thus, 
α-synemin also interacts with zyxin. 
  The interactions of synemin regions with zyxin were further tested in vitro by GST 
pull-down assays. SNβTII was specifically precipitated by immobilized GST-Zyx 1-572, 
while SNTIa, SNTIb, and SNTIII were not (Fig. 2F). These results confirmed the data 
obtained in the yeast two-hybrid β-galactosidase liquid culture assays. 
 
Analysis of the Interaction Affinity 
To provide a quantitative assessment of the interaction of SNβT with zyxin, surface plasmon 
resonance (SPR) were conducted as described in the “Materials and Methods” section. The 
purified GST tagged full length zyxin (GST-Zyx 1-572) was used as the ligand in the SPR 
analysis, whereas the purified recombinant FLAG-SNβT was used as the analyte. Zyxin 
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displayed positive interactions with increasing concentrations of SNβT as reflected by the 
sensorgrams (Fig. 3A). When the concentration of SNβT was high, the interaction reached 
saturation. The Kd value of the interaction was calculated as 5.68 × 10-8 M (Fig. 3B). This 
SPR analysis result not only provided quantitative information about the interaction but also 
further confirmed the in vitro interaction of human zyxin with synemin. 
 
Over Expression of SNβTII Significantly Blocked Localization of Endogenous Zyxin at Focal 
Adhesion (FA) Sites within the Transfected Cells 
To further examine the interaction of synemin with zyxin within a cellular context, Hela cells 
were transfected with EGFP-tagged SNβTII plasmids. Subcellular localizations of 
EGFP-SNβTII and zyxin were then examined with epifluorescence microscopy. Cells with 
moderate GFP expression level were selected for analysis. In comparison with surrounding 
cells, transient expression of EGFP-SNβTII within the transfected Hela cells resulted in 
significantly reduced zyxin localization at the FA sites (Fig. 4, D-F). Expression of EGFP 
alone within the transfected cells did not alter the localization pattern of endogenous zyxin 
(Fig. 4, A-C), indicating that zyxin localization to the focal adhesions (FAs) was blocked 
specifically by SNβTII. Note that loss of zyxin at the FAs was not due to disruption of the 
normal architecture of the FAs themselves, as illustrated by the intact FAs labeled with 
vinculin within the EGFP-SNβTII transfected Hela cells (Fig. 4, G-I), nor due to disruption 
of the normal architectures of other cytoskeletal components including vimentin IFs (Fig. 4, 
M-O) and actin cytoskeletons (Fig. 4, P-R). These results in toto suggested that interaction of 
exogenous SNβTII with zyxin blocked localization of endogenous zyxin at the FA sites 
within the transfected cells. Previous studies have shown that positioning of 
vasodilator-activated phosphoprotein (VASP) at FA sites is dependent on appropriate zyxin 
localization (Drees et al., 1999; Drees et al., 2000). We therefore examined whether loss of 
zyxin at FA sites by exogenous SNβTII would also block VASP localization to the FAs. 
Indeed, localization of VASP to the FAs was significantly reduced within 
EGFP-SNβTII-expressing cells (Fig. 4, J-L), indicating that it was a result of loss of zyxin at 
the FA sites.  
To examine whether loss of zyxin at the FA sites by exogenous SNβTII would also occur 
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in other mammalian cellular contexts, A-10 cells, a rat vascular smooth muscle cell line, and 
NIH/3T3 cells were also transfected with EGFP-SNβTII plasmids. Similar results of 
significantly reduced zyxin localization at the FA sites were also observed in A-10 cells (Fig. 
4, S-V) and NIH/3T3 cells (data not shown) transfected with EGFP-SNβTII, suggesting a 
general mechanism underpinning these phenotypes. By using fluorescent activated cell 
sorting (FACS), EGFP-SNβTII positive Hela cells were collected, lysed, and subjected to 
Western blot analysis. The results indicated that the zyxin, but not the vinculin, protein level 
within EGFP-SNβTII-expressing cells were significantly reduced (Fig. 4W), whereas the 
zyxin mRNA level was normal as indicated by RT-PCR when compared with the zyxin 
mRNA level within wild type Hela cells (Fig. 4X). Thus, loss of zyxin at the FA sites was 
resulted from a reduced zyxin protein level within the EGFP-SNβTII positive cells. 
 
Knockdown Synemin Did not Alter Zyxin Expression and Localization within Hela Cells 
To investigate whether loss of synemin will influence zyxin expression and localization 
within cells, synemin-knockout models were generated using siRNA specific to both human 
α- and β-synemins. Although it was previously shown that synemin is expressed in cultured 
Hela cells by mass spectrometry (Olsen et al., 2006), we also characterized and confirmed 
synemin expression in Hela cells by Western blotting (Fig. 5A), reverse transcriptase-PCR 
(Fig. 5B), and immunofluorescence microscopy (Fig. 5C). Western blotting showed that, 
compared to the relative equal and low amount of α- and β-synemins in both A-10 and 
UTSMC cells, α-synemin was highly expressed in Hela cells and β-synemin expression was 
very low (Fig. 5A). Reverse transcriptase-PCR using a specific primer pair that amplifies a 
~1 kb fragment from β-synemin mRNA and a ~2 kb fragment from α-synemin mRNA also 
showed that α-synemin was highly expressed in Hela cells (Fig. 5B). Synemin primarily 
co-localized with vimentin IFs within Hela cells as indicated by double immunofluorescence 
labeling of synemin and vimentin (Fig. 6C). Thus, these results in toto confirmed synemin 
expression in cultured Hela cells.  
Transfection of the Hela cells with the Hs_Dmn_4_HP siRNA for 72 hr (Dmn_4-Hela cells) 
resulted in a significant decrease in the synemin protein level, with no obvious change in 
protein levels of both zyxin and vinculin (Fig. 5E). Immunofluorescence staining of synemin 
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within Dmn_4-Hela cells indicated that synemin was absent in >98% of the cells (data not 
shown). Double immunofluorescence labeling of endogenous synemin and vimentin, or of 
synemin and zyxin, within Dmn_4-Hela cells showed that both vimentin filaments and zyxin 
localization remained intact. Other cytoskeletal architectures such as microfilaments and 
microtubules were also normal (data not shown). These results indicated that zyxin 
expression and localization is not affected when synemin is absent within cells. 
 
Synemin Is Essential for Cell Adhesion and Migration 
Intermediate filaments such as vimentin IFs (Ivaska et al., 2007) and keratin filaments (Green 
and Simpson, 2007; Magin et al., 2007) have been shown to play essential roles in cell 
adhesion and migration. Especially Kleeberger et al., recently reported that nestin, another 
mammalian type VI IF protein that shares similar molecular structure with synemin, is 
important for the migration and metastasis of prostate cancer cells (Kleeberger et al., 2007). 
This report raised our interest in examining whether synemin may play a role in cell adhesion 
and migration as well.  
In the cell adhesion assays, the calculated adhesion rate for the Dmn_4-Hela cells was 
29.9%, while for Hela cells transfected with the fluorescent negative control siRNA (Fl 
siRNA-Hela cells) was 54.8% (Fig. 6A). Statistical analysis indicated that Dmn_4-Hela cells 
exhibited significant compromised ability in adhering to the CellBIND surface tissue culture 
microplates (p < 0.05). The decreased adhesion rate of Dmn_4-Hela cells was not a result of 
decreased number of viable cells, in that the viability of Dmn_4-Hela cells was similar with 
wildtype Hela cells as measured by trypan blue staining using Guava viacount. No more than 
5-8% dead cells were detected in all experiments (data not shown). 
To examine the function of synemin in cell migration, the 2-D wound healing assays were 
performed using Dmn_4-Hela cells and Fl siRNA-Hela cells. Dmn_4-Hela cells exhibited 
markedly compromised ability in closing the “wound”, whereas Fl siRNA-Hela cells 
recovered most of the denuded area of the plate 48 hr after wounding (Fig. 6B). In the 
modified Boyden chamber assays, Fl siRNA-Hela cells exhibited a robust ability in migrating 
through the porous membranes, whereas traversing of Dmn_4-Hela cells through the 
membranes were markedly inhibited (Fig. 6, C and D). These results indicated that synemin 
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promoted the adhesion and migration of Hela cells. 
 
Discussion 
We have discovered zyxin as a novel interaction partner for the large type VI IF protein 
synemin. Using the entire tail domain of human β-synemin in a yeast two-hybrid screening of 
the human adult skeletal muscle total cDNA library, fifteen positive clones were obtained. 
Nine of the fifteen positive clones contained cDNA sequences encoding the full-length or 
truncated human zyxin (Fig. 1A). Subsequent yeast two-hybrid retransformation assays (Fig. 
1B), CO-IP assays (Fig. 1C), and in vitro protein-protein interaction assays (Fig. 2 and Fig. 3) 
indicated that interaction of synemin with zyxin is specific but not resulted from 
false-positives in the yeast two-hybrid screen. 
  The binding site for zyxin in human β-synemin was mapped to the C-terminal 332 amino 
acid region at the end of the tail domain (SNβTII, amino acid residues 922-1253) (Fig. 2, E 
and F). This is the first evidence that β-synemin contains a binding site for a protein that 
localizes to actin-membrane interactions and modulates cell-cell and cell-extracellular matrix 
adhesion. Transient expression of SNβTII within mammalian cells led to a markedly reduced 
zyxin protein level and loss of zyxin at the FA sites without disruption of other cellular 
architectures (Fig. 4). This could be that, in cells expressing exogenous SNβTII, zyxin was 
trapped within the cytoplasm by interacting with SNβTII, and the resulting mislocalization of 
zyxin would subsequently lead to its degradation. Zyxin has been shown to be able to travel 
between the nucleus and the FAs within cells, and may therefore mediate communications 
between these two subcellular compartments (Nix and Beckerle, 1997; Nix et al., 2001). 
Whether synemin and synemin-containing IFs are involved in regulating translocation of 
zyxin between the nucleus and the FAs remains to be elucidated.  
Our results also indicate that human α-synemin, which contains the 332 amino acid 
sequence (SNβTII), interacts with zyxin as well (Fig. 2E). We have previously shown that the 
312 amino acid insert that is only present within α-synemin (SNTIII) interacts specifically 
with vinculin and talin, both are cytoskeletal proteins present at actin-membrane interactions, 
thereby conferring additional functions to α-synemin (Sun et al., 2008b; Sun et al., 2008a). 
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Notably, SNTIII itself did not bind to zyxin (Fig. 2, E and F). But its presence interfered with 
the interaction of the SNβTII region with and thereby reduced the affinity of α-synemin for 
zyxin (Fig. 2E). Except for the additional insert within the tail domain, α-synemin is identical 
to and seems to share all the potential functions of the smaller β-synemin. However, it is 
possible that different ratios of α-synemin versus β-synemin would modulate interactions 
with their protein partners and thereby fulfill specific functions within different cellular 
contexts. This is reflected by the fact that both α- and β-synemins are differentially expressed 
in the three types (skeletal, cardiac, and smooth) of muscle cells (Titeux et al., 2001; Xue et 
al., 2004), as well as by the fact we found in this study that Hela cells, a human cervix 
epithelial adenocarcinoma cell line, express a very high level of α-synemin but very small 
amount of β-synemin (Fig. 5, A and B). 
The binding site for synemin in zyxin was mapped to the C-terminal region containing 
three tandem repeats of the LIM domains (Fig. 2, B and C). The LIM domains are modular 
protein-binding interfaces mediating protein-protein interactions (Feuerstein et al., 1994; 
Schmeichel and Beckerle, 1994; Kadrmas and Beckerle, 2004). And, it has been reported that 
the zyxin LIM domains contain binding sites for several other proteins such as cysteine-rich 
protein-1 (CRP-1) (Schmeichel and Beckerle, 1994) and p130Cas (Yi et al., 2002). Zyxin has 
also been implicated to act as an adapter protein that recruits different partners to appropriate 
subcellular compartments and promote their activity (Kadrmas and Beckerle, 2004). 
Especially the zyxin LIM domains are able to direct zyxin and Ena/VASP family proteins to 
FAs (Nix et al., 2001). Thus, synemin may be recruited simultaneously with Ena/VASP 
family proteins, CRP-1 and p130Cas by the zyxin LIM domains to the FAs and participate in 
actin remodeling and FA dynamics within cells. As a member of the Cas family, p130Cas is a 
cytoskeletal mechanosensor protein that regulates integrin signaling cascades and cell 
adhesion/cell motility (Defilippi et al., 2006). Upon mechanical extension by physiological 
forces, p130Cas is phosphorylated by src family kinase and thereby activates down stream 
signaling events (Sawada et al., 2006). Recruitment of synemin and p130Cas by zyxin may 
help in relaying mechanical forces from adhesion sites to the IF cytoskeletons within the cells, 
and thereby assist in cell adhesion and migration. How interactions of synemin isoforms with 
zyxin as well as those proteins binding to the zyxin LIM domains are regulated within living 
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cells awaits further exploration.  
We have also revealed novel functions for protein synemin in promoting cell adhesion and 
cell motility by RNAi studies (Fig. 6). These functions may be partially reflected by the 
evidence that synemin is able to interact with several proteins present in adhesion sites, such 
as vinculin, talin, and zyxin. Both vinculin and talin have been shown to regulate cell 
adhesion and migration (Critchley, 2004; Hu et al., 2007; Le Clainche and Carlier, 2008). 
And, zyxin has also been shown to be important in regulating actin filament assembly, with 
loss of zyxin within mice fibroblasts resulted in increased cell motility (Hoffman et al., 2006). 
Different ratios of α- and β-synemin may also modulate interactions with zyxin, vinculin, 
and talin, and thereby regulating cell adhesion and migration. Thus, a very high amount of 
α-synemin expressed within Hela cells could be beneficial for the invasiveness of theses 
cancer cells. Indeed, another mammalian type VI IF protein nestin shows similar functions in 
enhancing prostate cancer cell migration and metastasis (Kleeberger et al., 2007). 
Identification of interaction of synemin isoforms with zyxin broadened our understanding 
in the cellular functions of synemin. Synemin may link the synemin-containing 
heteropolymeric IFs to FA dynamics via interactions with zyxin, vinculin, and talin. As a 
result, synemin, like nestin, plays essential roles in cell adhesion and migration, and may 
contribute to cancer cell metastasis. 
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Figure 1. Zyxin was identified to interact with the β-synemin tail domain in the yeast two-hybrid 
screen of a human skeletal muscle cDNA library. (A) Schematic diagram showing human zyxin 
molecule as well as the zyxin regions from the nine positive clones resulted from the yeast two-hybrid 
screening. Only 8 clones are listed because two of the nine positive clones were identical (AD-Zyx 
322-572). The clone containing the shortest zyxin region (AD-Zyx 375-572) represents the 
C-terminal three tandem repeats of the LIM domains. (B) Phenotypes of the yeast two-hybrid 
retransformation assays. Each AD-Zyx construct were cotransformed again with DB-SNβT into the 
MaV203 yeast strains and were tested with the three reporter gene systems (LacZ, His3, and Ura3) of 
the ProQuest yeast two-hybrid system. They all exhibited phenotypes similar to the positive control, 
whereas the self activation controls of the bait only (DB-SNβT plus AD vector) and the prey only 
(AD-Zyx 1-572 plus DB vector) showed negative phenotypes. (C) Co-immunoprecipitation of 
synemin with zyxin. The experiments were performed as described in the “Materials and Methods” 
section. Synemin was specifically precipitated along with zyxin from Hela cell lysates using 
anti-human zyxin mAb immobilized on Protein A/G Plus beads. Synemin was not precipitated using 
immobilized anti-GAPDH mAb, or the Protein A/G Plus beads only, incubated with Hela cell lysates. 
Note that α-synemin was highly expressed in Hela cells.  
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Figure 2. Mapping the binding site within synemin and zyxin. (A-C) Synemin binds to the zyxin LIM 
domains. (A) Schematic diagram showing regions of human zyxin molecule and regions (Zyx 1-572, 
Zyx 82-572, Zyx 197-572, Zyx 375-572, and Zyx 1-383) used in the mapping studies. (B) Yeast 
two-hybrid β-galactosidase liquid culture assays testing the interaction of each zyxin region in the AD 
vector with DB-SNβT. The five controls (A-E) from the ProQuest yeast two-hybrid system were 
included as the standards of the interaction strength. The cotransformant of empty DB vector plus AD 
vector served as a negative control. The values οf β-galactosidase unit represent the mean ± s.d. from 
triplicates of the experiments. (C) FLAG immunoprecipitation assays. The experiments were 
performed as described in the "Materials and Methods" section. Both GST tagged Zyx 1-572 and Zyx 
375-572, but not GST-Zyx 1-383, were precipitated by FLAG-SNβΤ. (D-F) Zyxin binds to the 
C-terminal 332 amino acid sequence (SNβTII) within the β-synemin tail domain. (D) Schematic 
showing of human α- and β-synemin molecules as well as each region used in the yeast two-hybrid 
β-galactosidase liquid culture assays. The entire tail domain of β-synemin (SNβT, a.a. residues 
322-1253), the three sub-regions of SNβT (SNTIa, a.a. residues 321-579; SNTIb, a.a. residues 
580-920; and SNTβII, a.a. residues 922-1253), the 312 amino acid insert present only in α-synemin 
(SNTIII, a.a. residues 1153-1464), and the C-terminal region of α-synemin tail (SNαTII, a.a. residues 
922-1565) were cloned into the yeast two-hybrid DB vectors.(E) Yeast two-hybrid β-galactosidase 
liquid culture assays testing the interaction of each synemin region in DB vector with AD-Zyx 82-572. 
The co-transformants of empty DB vector plus AD vector and of DB-SNβT plus AD-zyx 82-572 
served as the negative and positive control, respectively. The values οf β-galactosidase unit represent 
the mean ± s.d. from triplicates of the experiments. Note that both SNTβII and SNTαII showed 
interaction with Zyx 82-572 as compared with the positive control. (F) Each FLAG-tagged synemin 
fusion protein was incubated with purified GST-Zyx 1-572 in the GST pull-down assays. GST-Zyx 
1-572 precipitated only FLAG-SNβTII but not FLAG-SNTIa, FLAG-SNTIb, and FLAG-SNTIII. 
GST alone incubated with FLAG-SNβTII served as a negative control. 
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Figure 3. Biacore surface plasmon resonance analyzing affinity of the interaction between SNβT and 
zyxin. (A) Reference subtracted sensorgrams showing interaction of purified recombinant zyxin with 
SNβT. Purified GST-Zyx 1-572 was immobilized on a CM5 sensorchip as the ligand. Increasing 
concentrations of FLAG-SNβT (250 nM, 500 nM, 1000 nM, 2000 nM, and 3000 nM) were injected 
as the analyte over the sensorchip with an association time of 180 seconds and a dissociation time of 
100 seconds. Note that the interaction reached saturation at high concentrations (2000 nM and 3000 
nM) of FLAG-SNβT injected. RU denotes response units. (B) Affinity of the interaction was 
calculated based upon resulted RUs from two separated experiments. The Kd value for the interaction 
was estimated at 5.68 × 10-8 M.  
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Figure 4. Transient expression of SNβTII in mammalian cells led to loss of zyxin at the FA sites. 
(A-R) Transient expression of EGFP alone or EGFP-SNβTII within Hela cells. Cells were double 
labeled with anti-GFP pAb in green and with each appropriate mAb or reagent to the corresponding 
endogenous protein in red as indicated. (F) and (L) represent the boxed area in (E) and (K), 
respectively. Asterisks in (E), (F), (K), and (L) indicate GFP positive cells. Note that EGFP-SNβTII 
positive cells exhibited significantly reduced level of zyxin (F) and VASP (L) at the FA sites in 
comparison with surrounding cells. EGFP alone did not block zyxin to the FAs (A-C). The normal 
architectures of the GFP positive cells were not disrupted as indicated by labeling FAs (G-I), IFs 
(M-O), and F-actin (P-R) with vinculin, vimentin, and phalloidin, respectively. (S-V) Transient 
expression of EGFP-SNβTII within A-10 cells. Arrows indicate the EGFP-SNβTII positive cells. 
Localization of zyxin, but not vinculin, at the FA sites was also significantly reduced. (X) Western 
blotting showing significantly decreased zyxin, but not vinculin, protein level in EGFP-SNβTII 
positive Hela cells. Approximately 10,000 cells were collected by flow cytometry, lysed, and 
subjected to SDS-PAGE and Western blotting. Wildtype Hela cells without transfection served as the 
control. (W) RT-PCR showing similar mRNA level of zyxin and vinculin in both EGFP-SNβTII 
positive Hela cells and wildtype Hela cells. 
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Figure 5. Loss of synemin did not alter the protein level and localization of zyxin within Hela cells. 
(A-C) Characterization of synemin expression within Hela cells. (A) Western blotting showing that 
α-synemin was highly expressed in Hela cells, whereas both α- and β-synemin were expressed at a 
relatively similar level in A-10 and UTSMC cells. (B) RT-PCR showing that α-synemin mRNA was 
highly expressed within Hela cells. (C) Double labeling of synemin (green) and vimentin (red) with 
anti-synemin 2856 pAb and anti-vimentin mAb V9 showed that synemin co-localized with vimentin 
in filamentous structures within Hela cells. (D-F) Knockdown synemin expression within Hela cells 
using siRNA. (D) Quantitative PCR analyzing synemin mRNA levels within Hela cells transfected 
with siRNAs. ~87% synemin mRNA was knockdown within Hela cells treated with HS_Dmn_4_HP 
(Dmn_4) siRNA for 72 hr. (E) Western blotting showing synemin (Syn) knockdown within Hela cells 
treated with Dmn_4 siRNA for 72 hr. Wildtype Hela cells (Wt), Hela cells treated with transfection 
reagent only (mock), and Hela cells transfected with Alexa Fluor 488 labeled negative control siRNA 
(Fl siRNA) served as controls. Expression levels of α-tubulin (α-Tub) served as a household protein 
standard. Knockdown of synemin within Hela cells did not change the protein levels of both vinculin 
(Vin) and zyxin (Zyx). (F) Knockdown of synemin did not change the filamentous organization of 
vimentin and the localization patterns of zyxin within Dmn_4 siRNA treated Hela cells. 
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Figure 6. Synemin promotes cell adhesion and cell motility. (A) Hela cells with synemin knockdown 
(Dmn_4) exhibited compromised adhesion to the culture plates when compared with Hela cells 
transfected with Fl siRNA (*, p = 0.024). (B) Dmn_4 siRNA transfected Hela cells exhibited 
markedly compromised healing ability in the wound healing assays 48 hr after wounding. 
Representative photos from three independent experiments are shown. Bar, 100 μm. (C) Much fewer 
cells traversed the porous membrane in the modified Boyden chamber assays when Hela cells were 
treated with Dmn_4 siRNA than Hela cells treated with Fl siRNA did. Black dots in the images were 
those 8 μm pores on the membrane. Bar, 100 μm. (D) Number of cells that traversed the uncoated 
membranes in the modified Boyden chamber assays. HPF, high-power field 
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GENERAL CONCLUSIONS 
 
The overall goal of the research presented in this dissertation is to extend our 
understanding of the cellular functions of the mammalian synemin isoforms. By identifying 
and studying interactions of synemin isoforms with their specific protein partners, the exact 
role of synemin within mammalian cells could be gradually clarified. And, these efforts 
should provide useful information for future investigations on this large unique type VI 
intermediate filament protein.  
Although previous results from our lab showed that avian synemin interacts with 
vinculin, whether the two major mammalian synemin isoforms interact with vinculin and its 
muscle specific isoform metavinculin has been unclear. In addition, a recent study 
demonstrated co-precipitation of human synemin with talin from hepatic stellate cell extracts 
and co-localization of synemin with talin within cultured cells. However, evidence of a direct 
interaction of mammalian synemin with talin has still been missing. In order to study direct 
interactions of mammalian synemins with vinculin/metavinculin and talin, several different 
approaches testing protein-protein interactions were conducted using bacterially expressed 
and purified recombinant synemin regions as well as purified recombinant regions from 
vinculin/metavinculin and talin. These studies discovered that the 312 amino acid insert 
(SNTIII) present only within α-synemin exhibited specific interactions with both the 
vinculin/metavinculin tail domain and the talin rod domain in both blot overlay assays and 
GST pull-down assays, whereas regions of β-synemin did not. Both the vinculin tail domain 
and the talin rod domain exhibited saturated interaction with SNTIII with similar affinities in 
ELISA solid phase binding assays. Furthermore, it was shown that vinculin and talin interact 
with SNTIII in a competitive manner in the ELISA solid phase binding assays, suggesting 
they do not bind to synemin simultaneously in vivo.  
Interactions of SNTIII with both vinculin and talin were further supported by evidence 
that EGFP tagged SNTIII demostrated specific co-localization with both vinculin and talin in 
the focal adhesions within transfected mammalian cells. In contrast, β-synemin regions 
showed distinct localization patterns, but without specific localization at focal adhesion sites. 
These results in toto indicate that α-synemin, but not β-synemin, is the isoform that interacts 
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specifically with vinculin/metavinculin and talin. Interestingly, analysis of the primary 
sequence of the SNTIII region indicates that it is composed of seven ~39 amino acid tandem 
repeats, with each repeat containing a specific S/T-X-R-Q/H motif. This unique primary 
sequence arrangement, and possibly of the corresponding unique secondary and tertiary 
structures, of SNTIII may be the underlying basis for its specific interactions with both 
vinculin and talin. 
    In order to extend our understanding of the cellular function of the smaller β-synemin, 
novel interactions of β-synemin with its protein partners were discovered by yeast 
two-hybrid screening assays. By using the entire β-synemin tail domain (SNβT) as the bait in 
screening against a human adult skeletal muscle total cDNA library, the LIM domain protein 
zyxin was pulled out as one of the β-synemin interacting partners. Mapping the respective 
binding site within these two molecules using β-galactosidase liquid culture assays indicated 
that synemin binds specifically to the LIM domains of zyxin, whereas the zyxin binding site 
within the β-synemin molecule was located within the C-terminal ~300 amino acid (SNβTII) 
sequence at the end of the β-synemin tail domain. Because α-synemin shares with β-synemin 
the same sequence containing the binding site for zyxin, it is therefore not surprising to 
observe interaction of α-synemin with zyxin as well. However, the presence of the unique 
312 amino acid insert within α-synemin may interfere with the interaction, as reflected by a 
lower affinity of the α-synemin tail domain for zyxin than that of the β-synemin tail domain 
in the β-galactosidase liquid culture assays. In vitro protein-protein interaction assays, such 
as GST pull-down assays and surface plasmon resonance assays, provided further support for 
a direct interaction of the β-synemin tail domain with zyxin. In addition, synemin 
co-precipitated with zyxin from mammalian cell extracts. When expressed within 
mammalian cells, EGFP-tagged SNβTII led to a markedly reduced protein level of zyxin and 
the loss of zyxin localization at the focal adhesion sites. These results suggest synemin and 
zyxin associate with each other in vivo. Zyxin has been implicated as being essential in 
modulating actin cytoskeletons at actin-membrane interactions as well as in cell adhesion and 
migration. Thus, synemin may link the heteropolymeric intermediate filaments to these 
cellular processes within synemin-expressing cells. Indeed, novel functions of synemin in 
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cell adhesion and cell motility is presented in this dissertation. RNAi studies knocking down 
synemin expression within Hela cells, a human cervix epithelial adenocarcinoma cell line, 
led to markedly compromised cell adhesion and migration.  
    Taken in toto, the research presented in this dissertation demonstrates that mammalian 
synemins interact differentially with the cytoskeletal proteins vinculin/metavinculin, talin, 
and zyxin, all of which are present in cell-cell and/or cell-substratum adhesion sites, and are 
essential in regulating cell adhesion and migration. Thus, it is our hypothesis that synemin 
plays important roles in linking the heteropolymeric intermediate filaments to these adhesion 
sites within synemin-expressing cells. Different ratios of α- versus β-synemin may modulate 
the interactions of mammalian synemins with their protein partners, and thereby regulate the 
strength of the linkages between the synemin-containing heteropolymeric intermediate 
filaments and the adhesion sites in mammalian muscle cells, and more generally, in all 
mammalian cells expressing synemin.  
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